Signal	O
transduction	O
pathways	O
activated	O
in	O
endothelial	B-cell_type
cells	I-cell_type
following	O
infection	O
with	O
Chlamydia	O
pneumoniae	O
.	O

Chlamydia	O
pneumoniae	O
is	O
an	O
important	O
respiratory	O
pathogen	O
.	O

Recently	O
,	O
its	O
presence	O
has	O
been	O
demonstrated	O
in	O
atherosclerotic	O
lesions	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
C.	O
pneumoniae-mediated	O
activation	O
of	O
endothelial	B-cell_type
cells	I-cell_type
and	O
demonstrated	O
an	O
enhanced	O
expression	O
of	O
endothelial	B-protein
adhesion	I-protein
molecules	I-protein
followed	O
by	O
subsequent	O
rolling	O
,	O
adhesion	O
,	O
and	O
transmigration	O
of	O
leukocytes	B-cell_type
(	O
monocytes	B-cell_type
,	O
granulocytes	B-cell_type
)	O
.	O

These	O
effects	O
were	O
blocked	O
by	O
mAbs	B-protein
against	O
endothelial	B-protein
and/or	I-protein
leukocyte	I-protein
adhesion	I-protein
molecules	I-protein
(	O
beta1	B-protein
and	I-protein
beta2	I-protein
integrins	I-protein
)	O
.	O

Additionally	O
,	O
activation	O
of	O
different	O
signal	O
transduction	O
pathways	O
in	O
C.	B-cell_type
pneumoniae-infected	I-cell_type
endothelial	I-cell_type
cells	I-cell_type
was	O
shown	O
:	O
protein	O
tyrosine	O
phosphorylation	O
,	O
up-regulation	O
of	O
phosphorylated	O
p42/p44	B-protein
mitogen-activated	I-protein
protein	I-protein
kinase	I-protein
,	O
and	O
NF-kappaB	B-protein
activation/translocation	O
occurred	O
within	O
10-15	O
min	O
.	O

Increased	O
mRNA	B-RNA
and	O
surface	O
expression	O
of	O
E-selectin	B-protein
,	O
ICAM-1	B-protein
,	O
and	O
VCAM-1	B-protein
were	O
noted	O
within	O
hours	O
.	O

Thus	O
,	O
C.	O
pneumoniae	O
triggers	O
a	O
cascade	O
of	O
events	O
that	O
could	O
lead	O
to	O
endothelial	O
activation	O
,	O
inflammation	O
,	O
and	O
thrombosis	O
,	O
which	O
in	O
turn	O
may	O
result	O
in	O
or	O
may	O
promote	O
atherosclerosis	O
.	O

X	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
Sa	NULL
reJournal	NULL
f	NULL
Signal	NULL
Transduction	NULL
Pathways	NULL
Activated	NULL
in	NULL
'	NULL
Immunolo	NULL
gy	NULL
Endothelial	NULL
Cells	NULL
Following	NULL
Infection	NULL
with	NULL
Chlamydia	NULL
pneumoniae	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Matthias	NULL
Kriill	NULL
,	NULL
Andrea	NULL
C.	NULL
Klucken	NULL
,	NULL
Frederik	NULL
N.	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
(	NULL
Elana	NULL
;	NULL
i	NULL
)	NULL
;	NULL
Is	NULL
current	NULL
as	NULL
Wuppermann	NULL
,	NULL
Oliver	NULL
Fuhrmann	NULL
,	NULL
Christian	NULL
Magerl	NULL
,	NULL
Joachim	NULL
'	NULL
Seybold	NULL
,	NULL
Stefan	NULL
Hippenstiel	NULL
,	NULL
Johannes	NULL
H.	NULL
Hegemann	NULL
,	NULL
Christian	NULL
A.	NULL
Jantos	NULL
and	NULL
Norbert	NULL
Suttorp	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:4834-4841	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4834	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
38	NULL
articles	NULL
,	NULL
17	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4834	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Signal	NULL
Transduction	NULL
Pathways	NULL
Activated	NULL
in	NULL
Endothelial	NULL
Cells	NULL
Following	NULL
Infection	NULL
with	NULL
Chlamydia	NULL
pneumoniae	NULL
'	NULL
Matthias	NULL
Kriill	NULL
,	NULL
*	NULL
Andrea	NULL
C.	NULL
Klucken	NULL
,	NULL
*	NULL
Frederik	NULL
N.	NULL
Wuppermann	NULL
,	NULL
'	NULL
Oliver	NULL
Fuhrmann	NULL
,	NULL
*	NULL
Christian	NULL
Magerl	NULL
,	NULL
*	NULL
Joachim	NULL
Seybold	NULL
,	NULL
*	NULL
Stefan	NULL
Hippenstiel	NULL
,	NULL
*	NULL
Johannes	NULL
H.	NULL
Hegemann	NULL
,	NULL
*	NULL
Christian	NULL
A.	NULL
Jantos	NULL
,	NULL
``	NULL
and	NULL
Norbert	NULL
Chlamydia	NULL
pneumoniae	NULL
is	NULL
an	NULL
important	NULL
respiratory	NULL
pathogen	NULL
.	NULL

Recently	NULL
,	NULL
its	NULL
presence	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
atherosclerotic	NULL
lesions	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
characterized	NULL
C.	NULL
preumoniae-mediated	NULL
activation	NULL
of	NULL
endothelial	NULL
cells	NULL
and	NULL
demonstrated	NULL
an	NULL
enhanced	NULL
expression	NULL
of	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
followed	NULL
by	NULL
subsequent	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transmigration	NULL
of	NULL
leukocytes	NULL
(	NULL
monocytes	NULL
,	NULL
granulocytes	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
blocked	NULL
by	NULL
mAbs	NULL
against	NULL
endothelial	NULL
and/or	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
(	NULL
,	NULL
and	NULL
B	NULL
,	NULL
integrins	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
activation	NULL
of	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
C.	NULL
preumoniae-infected	NULL
endothelial	NULL
cells	NULL
was	NULL
shown	NULL
:	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
up-regulation	NULL
of	NULL
phosphorylated	NULL
p42/p44	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
and	NULL
activation/translocation	NULL
occurred	NULL
within	NULL
10-15	NULL
min	NULL
.	NULL

Increased	NULL
mRNA	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
were	NULL
noted	NULL
within	NULL
hours	NULL
.	NULL

Thus	NULL
,	NULL
C.	NULL
preumoniae	NULL
triggers	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
that	NULL
could	NULL
lead	NULL
to	NULL
endothelial	NULL
activation	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
thrombosis	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
result	NULL
in	NULL
or	NULL
may	NULL
promote	NULL
atherosclerosis	NULL
.	NULL

lular	NULL
bacterium	NULL
,	NULL
is	NULL
a	NULL
widespread	NULL
respiratory	NULL
pathogen	NULL
causing	NULL
pneumonia	NULL
,	NULL
bronchitis	NULL
,	NULL
sinusitis	NULL
,	NULL
and	NULL
pharyngitis	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
chronic	NULL
C.	NULL
pneumoniae	NULL
infection	NULL
has	NULL
been	NULL
suggested	NULL
as	NULL
a	NULL
trigger	NULL
and	NULL
promoter	NULL
of	NULL
inflammatory	NULL
reactions	NULL
and	NULL
development	NULL
of	NULL
vascular	NULL
lesions	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
demonstration	NULL
(	NULL
electron	NULL
microscopy	NULL
,	NULL
immunocytochemistry	NULL
,	NULL
PCR	NULL
)	NULL
of	NULL
C.	NULL
pneumoniae	NULL
in	NULL
atherosclerotic	NULL
plaques	NULL
and	NULL
the	NULL
serological	NULL
association	NULL
between	NULL
C.	NULL
pneumoniae	NULL
infection	NULL
and	NULL
coronary	NULL
heart	NULL
disease	NULL
(	NULL
4-8	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
C.	NULL
pneumoniae	NULL
in	NULL
atheroma	NULL
formation	NULL
has	NULL
not	NULL
been	NULL
studied	NULL
in	NULL
detail	NULL
.	NULL

Monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
smooth	NULL
muscle	NULL
cells	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
susceptible	NULL
for	NULL
C.	NULL
preumoniae	NULL
infection	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Chlamydiae	NULL
may	NULL
reside	NULL
and	NULL
replicate	NULL
in	NULL
monocytes/	NULL
macrophages	NULL
and	NULL
induce	NULL
a	NULL
chronic	NULL
immune	NULL
activation	NULL
resulting	NULL
in	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
3	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IFN-y	NULL
release	NULL
as	NULL
well	NULL
as	NULL
up-regulation	NULL
of	NULL
CD14	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
C.	NULL
preumoniae-induced	NULL
endothelial	NULL
cell	NULL
alterations	NULL
and	NULL
C.	NULL
preumoniae-mediated	NULL
interactions	NULL
among	NULL
all	NULL
cell	NULL
types	NULL
involved	NULL
in	NULL
the	NULL
progress	NULL
of	NULL
atherosclerosis	NULL
.	NULL

Airway-derived	NULL
organisms	NULL
may	NULL
be	NULL
able	NULL
to	NULL
spread	NULL
systemically	NULL
via	NULL
at	NULL
least	NULL
two	NULL
different	NULL
ways	NULL
:	NULL
1	NULL
)	NULL
carried	NULL
within	NULL
monocytes	NULL
following	NULL
pulmonary	NULL
infection	NULL
or	NULL
2	NULL
)	NULL
by	NULL
direct	NULL
access	NULL
to	NULL
the	NULL
blood	NULL
stream	NULL
causing	NULL
a	NULL
short	NULL
interval	NULL
of	NULL
chlamydial	NULL
bacteremia	NULL
.	NULL

Chronic	NULL
monocyte/macrophage	NULL
infection	NULL
as	NULL
well	NULL
as	NULL
direct	NULL
activation	NULL
of	NULL
endothelial	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
local	NULL
inflammation	NULL
by	NULL
inducing	NULL
Chlamydia	NULL
pneumoniae	NULL
,	NULL
a	NULL
Gram-negative	NULL
obligate	NULL
intracel-	NULL
*Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Justus-Licbig-University	NULL
,	NULL
Giessen	NULL
,	NULL
Germany	NULL
;	NULL
*In-stitute	NULL
of	NULL
Medical	NULL
Microbiology	NULL
,	NULL
Justus-Liebig-University	NULL
,	NULL
Giessen	NULL
,	NULL
Germany	NULL
;	NULL
*Insti-tute	NULL
of	NULL
Microbiology	NULL
,	NULL
Heinrich-Heine-University	NULL
,	NULL
Diisseldorf	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
SCharite	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Humboldt-University	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
29	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
4	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

'This	NULL
work	NULL
was	NULL
in	NULL
part	NULL
supported	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
(	NULL
SFB547/B2	NULL
to	NULL
N.S	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Justus-Liebig-University	NULL
Award	NULL
1994	NULL
(	NULL
to	NULL
J.H.H	NULL
.	NULL
)	NULL

,	NULL
and	NULL
the	NULL
Verband	NULL
der	NULL
Chemischen	NULL
Industrie	NULL
(	NULL
to	NULL
J.H.H	NULL
.	NULL
)	NULL

.	NULL

N.	NULL
Suttorp	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Her-mann	NULL
and	NULL
Lilly	NULL
Schilling	NULL
Professorship	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Norbert	NULL
Suttorp	NULL
,	NULL
Charite	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine/Infectious	NULL
Diseases	NULL
Humboldt-University	NULL
,	NULL
Augusten-burger	NULL
Platz	NULL
1	NULL
,	NULL
13353	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
norbert.suttorp	NULL
@	NULL
charite.de	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
4834-4841.	NULL
cytokine	NULL
release	NULL
and	NULL
increased	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
result	NULL
in	NULL
enhanced	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
leukocytes	NULL
.	NULL

Adhkesion	NULL
of	NULL
circulating	NULL
leukocytes	NULL
to	NULL
endothelial	NULL
cells	NULL
is	NULL
an	NULL
early	NULL
step	NULL
in	NULL
an	NULL
inflammatory	NULL
reaction	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
complex	NULL
communication	NULL
between	NULL
the	NULL
cell	NULL
types	NULL
involved	NULL
.	NULL

Recent	NULL
studies	NULL
revealed	NULL
that	NULL
multiple	NULL
receptor-ligand	NULL
pairs	NULL
act	NULL
sequentially	NULL
and	NULL
in	NULL
an	NULL
overlapping	NULL
manner	NULL
to	NULL
effect	NULL
initial	NULL
attachment	NULL
,	NULL
rolling	NULL
,	NULL
firm	NULL
adhesion	NULL
,	NULL
and	NULL
finally	NULL
transmigration	NULL
of	NULL
leukocytes	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

For	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
activated	NULL
endothelial	NULL
cells	NULL
,	NULL
separate	NULL
receptor-ligand	NULL
pairs	NULL
are	NULL
involved	NULL
:	NULL
ICAM-1	NULL
and	NULL
$	NULL
;	NULL
,	NULL
integrins	NULL
(	NULL
CD11a/	NULL
CD18	NULL
,	NULL
CD11b/CD18	NULL
)	NULL
,	NULL
VCAM-1	NULL
and	NULL
very	NULL
late	NULL
Ag-4	NULL
(	NULL
VLA	NULL
,	NULL
)	NULL
,	NULL
``	NULL
P-selectin	NULL
and	NULL
P-selectin-glycoprotein	NULL
ligand-1	NULL
,	NULL
E-selectin	NULL
and	NULL
E-selectin	NULL
ligand-1	NULL
,	NULL
as	NULL
well	NULL
as	NULL
sialyl	NULL
Lewis*	NULL
and	NULL
related	NULL
carbohydrates	NULL
on	NULL
leukocytes	NULL
(	NULL
14	NULL
,	NULL
17-19	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
first	NULL
objective	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
assess	NULL
C.	NULL
pneumonia	NULL
's	NULL
capability	NULL
to	NULL
infect	NULL
and	NULL
activate	NULL
HUVEC	NULL
and	NULL
human	NULL
aortic	NULL
endothelial	NULL
cells	NULL
(	NULL
HAEC	NULL
)	NULL
.	NULL

Enhanced	NULL
expression	NULL
of	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
was	NULL
accompanied	NULL
by	NULL
an	NULL
increased	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transmigration	NULL
of	NULL
polymorphonuclear	NULL
leukocytes	NULL
(	NULL
PMN	NULL
)	NULL
and	NULL
monocytes	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
reduced	NULL
by	NULL
mAbs	NULL
directed	NULL
against	NULL
different	NULL
adhesion	NULL
molecules	NULL
on	NULL
leukocytes	NULL
and/or	NULL
endothelial	NULL
cells	NULL
.	NULL

There	NULL
is	NULL
limited	NULL
knowledge	NULL
of	NULL
the	NULL
mechanisms	NULL
of	NULL
C.	NULL
preumoniae	NULL
entry	NULL
into	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
chlamydial	NULL
growth	NULL
cycle	NULL
is	NULL
initiated	NULL
when	NULL
an	NULL
infectious	NULL
elementary	NULL
body	NULL
(	NULL
EB	NULL
)	NULL
attaches	NULL
to	NULL
a	NULL
susceptible	NULL
target	NULL
cell	NULL
,	NULL
promoting	NULL
entry	NULL
into	NULL
a	NULL
host	NULL
cell-derived	NULL
phagocytic	NULL
vesicle	NULL
.	NULL

EB	NULL
develop	NULL
into	NULL
reticular	NULL
bodies	NULL
,	NULL
a	NULL
process	NULL
that	NULL
could	NULL
be	NULL
detected	NULL
metabolically	NULL
within	NULL
15	NULL
min	NULL
and	NULL
microscopically	NULL
12-15	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
Chlamydiae	NULL
to	NULL
HEp-2	NULL
and	NULL
Hela-229	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
length	NULL
of	NULL
the	NULL
complete	NULL
developmental	NULL
cycle	NULL
,	NULL
as	NULL
studied	NULL
in	NULL
cell	NULL
culture	NULL
models	NULL
,	NULL
is	NULL
48-72	NULL
h	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

?	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
VLA	NULL
,	NULL
very	NULL
late	NULL
Ag	NULL
;	NULL
HAEC	NULL
,	NULL
human	NULL
aortic	NULL
endothelial	NULL
cells	NULL
;	NULL
PMN	NULL
,	NULL
polymorphonuclear	NULL
leukocytes	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen	NULL
activated	NULL
protein	NULL
kinase	NULL
;	NULL
IPU	NULL
,	NULL
inclusion	NULL
forming	NULL
unit	NULL
;	NULL
EB	NULL
,	NULL
elementary	NULL
body	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Almost	NULL
nothing	NULL
is	NULL
known	NULL
about	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
initiated	NULL
in	NULL
the	NULL
host	NULL
cell	NULL
upon	NULL
Chlamydige-target	NULL
cell	NULL
interaction	NULL
(	NULL
intracellular	NULL
Ca	NULL
``	NULL
*-increase	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
and	NULL
tyrosine	NULL
kinases	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
MAPK	NULL
)	NULL
,	NULL
NF-KB	NULL
translocation	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
second	NULL
objective	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
assess	NULL
C.	NULL
preumoniae	NULL
's	NULL
capability	NULL
to	NULL
activate	NULL
host	NULL
cell	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

C.	NULL
pneumoniae	NULL
induced	NULL
an	NULL
immediate	NULL
increase	NULL
of	NULL
total	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
HUVEC	NULL
and	NULL
HAEC	NULL
,	NULL
especially	NULL
of	NULL
phosphorylated	NULL
p42/p44	NULL
MAPK	NULL
and	NULL
an	NULL
activation/translocation	NULL
of	NULL
endothelial	NULL
cell	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
subsequently	NULL
increased	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
indicate	NULL
that	NULL
C.	NULL
pneumoniae	NULL
can	NULL
infect	NULL
and	NULL
activate	NULL
human	NULL
endothelial	NULL
cells	NULL
and	NULL
suggest	NULL
that	NULL
C.	NULL
pneumoniae-induced	NULL
endothelial	NULL
cell	NULL
alterations	NULL
may	NULL
promote	NULL
atherosclerosis	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
Tissue	NULL
culture	NULL
plasticware	NULL
was	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Heidel-berg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

MCDB131	NULL
medium	NULL
,	NULL
PBS	NULL
,	NULL
trypsin-EDTA	NULL
solution	NULL
,	NULL
HEPES	NULL
,	NULL
and	NULL
FCS	NULL
were	NULL
from	NULL
Life	NULL
Technologies	NULL
(	NULL
Karlsruhe	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Collagenase	NULL
(	NULL
CLS	NULL
type	NULL
II	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Worthington	NULL
Biochemical	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Percoll	NULL
and	NULL
Ficoll-Paque	NULL
were	NULL
obtained	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Monoclonal	NULL
Abs	NULL
Purified	NULL
freeze-dried	NULL
mAb	NULL
directed	NULL
against	NULL
CD11a	NULL
(	NULL
25.3.1	NULL
)	NULL
,	NULL
CD1lc	NULL
(	NULL
BU15	NULL
)	NULL
,	NULL
CD18	NULL
(	NULL
7E4	NULL
)	NULL
,	NULL
CD29	NULL
(	NULL
Lia	NULL
1/2	NULL
)	NULL
,	NULL
CD31	NULL
(	NULL
Hec-7	NULL
)	NULL
,	NULL
CD49d	NULL
(	NULL
HP2/1	NULL
)	NULL
,	NULL
and	NULL
P-selectin	NULL
(	NULL
CLB/thromb6	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Coulter/Immunotech	NULL
(	NULL
Mar-seille	NULL
,	NULL
France	NULL
)	NULL
;	NULL
mAb	NULL
directed	NULL
against	NULL
CD11b	NULL
(	NULL
clone	NULL
44	NULL
)	NULL
,	NULL
E-selectin	NULL
(	NULL
1.2B6	NULL
)	NULL
,	NULL
ICAM-1	NULL
(	NULL
15.2	NULL
)	NULL
,	NULL
and	NULL
VCAM-1	NULL
(	NULL
1.G11B1	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Dianova	NULL
(	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
Preparation	NULL
of	NULL
HUVEC	NULL
.	NULL

Cells	NULL
were	NULL
isolated	NULL
from	NULL
umbilical	NULL
cord	NULL
veins	NULL
and	NULL
identified	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Jaffe	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
obtained	NULL
from	NULL
collagenase	NULL
digestion	NULL
were	NULL
washed	NULL
,	NULL
resuspended	NULL
in	NULL
MCDB131/5	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
seeded	NULL
into	NULL
tissue	NULL
culture	NULL
flasks	NULL
(	NULL
80	NULL
cm	NULL
)	NULL
,	NULL
well	NULL
plates	NULL
,	NULL
or	NULL
glass	NULL
coverslips	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

HAEC	NULL
.	NULL

HAEC	NULL
were	NULL
obtained	NULL
from	NULL
Clonetics	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

HAEC	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
using	NULL
EGM-2/2	NULL
%	NULL
FCS	NULL
(	NULL
Clonetics	NULL
)	NULL
in	NULL
tissue	NULL
culture	NULL
flasks	NULL
(	NULL
80	NULL
cm	NULL
)	NULL
,	NULL
well	NULL
plates	NULL
,	NULL
or	NULL
glass	NULL
coverslips	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
PMN	NULL
.	NULL

Heparinized	NULL
human	NULL
donor	NULL
blood	NULL
was	NULL
centrifuged	NULL
in	NULL
a	NULL
discontinuous	NULL
Percoll	NULL
gradient	NULL
to	NULL
yield	NULL
a	NULL
PMN	NULL
fraction	NULL
of	NULL
>	NULL
97	NULL
%	NULL
purity	NULL
as	NULL
described	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Isolation	NULL
and	NULL
labeling	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
anti-coagulated	NULL
whole	NULL
blood	NULL
or	NULL
from	NULL
buffy	NULL
coats	NULL
by	NULL
centrifugation	NULL
on	NULL
Ficoll-Paque	NULL
density	NULL
gradient	NULL
followed	NULL
by	NULL
counterflow	NULL
centrifugation	NULL
elutriation	NULL
in	NULL
a	NULL
Beckman	NULL
J6-MC	NULL
centrifuge	NULL
using	NULL
a	NULL
JE-6	NULL
elutriation	NULL
rotor	NULL
and	NULL
a	NULL
5.5-ml	NULL
Sanderson	NULL
chamber	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Monocyte	NULL
suspension	NULL
was	NULL
90	NULL
+	NULL
4	NULL
%	NULL
(	NULL
n	NULL
=	NULL
20	NULL
)	NULL
pure	NULL
with	NULL
7	NULL
%	NULL
lymphocytes	NULL
and	NULL
<	NULL
2	NULL
%	NULL
granulocytes	NULL
as	NULL
determined	NULL
by	NULL
light	NULL
scatter	NULL
(	NULL
FACScan	NULL
;	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Chlamydial	NULL
strain	NULL
C.	NULL
pneumoniae	NULL
strain	NULL
GiD	NULL
was	NULL
used	NULL
.	NULL

This	NULL
strain	NULL
was	NULL
originally	NULL
isolated	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
bronchitis	NULL
.	NULL

The	NULL
isolate	NULL
was	NULL
identified	NULL
to	NULL
be	NULL
C.	NULL
preumoniae	NULL
by	NULL
staining	NULL
inclusions	NULL
formed	NULL
in	NULL
cell	NULL
culture	NULL
with	NULL
a	NULL
species-specific	NULL
mAb	NULL
and	NULL
by	NULL
sequence	NULL
analysis	NULL
of	NULL
the	NULL
entire	NULL
ompl	NULL
gene	NULL
(	NULL
31	NULL
)	NULL
.	NULL

C.	NULL
pneumoniae	NULL
GiD	NULL
was	NULL
grown	NULL
to	NULL
high	NULL
titers	NULL
in	NULL
cyclohexamide-treated	NULL
HEp-2	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Infected	NULL
monolayers	NULL
were	NULL
harvested	NULL
from	NULL
culture	NULL
flasks	NULL
and	NULL
sonicated	NULL
for	NULL
30	NULL
s.	NULL
Cellular	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
500	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Aliquots	NULL
diluted	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
sucrose-phosphate-glutamate	NULL
buffer	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
were	NULL
stored	NULL
at	NULL
-75°C	NULL
until	NULL
use	NULL
.	NULL

Titration	NULL
in	NULL
cyclohexamide-treated	NULL
Hep-2	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
thawed	NULL
aliquot	NULL
(	NULL
in	NULL
triplicate	NULL
)	NULL
.	NULL

Chlamydiae	NULL
concentrations	NULL
used	NULL
were	NULL
expressed	NULL
as	NULL
inclusion	NULL
forming	NULL
units	NULL
(	NULL
IFU	NULL
)	NULL
/ml	NULL
.	NULL

C.	NULL
pneumoniae	NULL
infection	NULL
assay	NULL
C.	NULL
pneumoniae	NULL
suspensions	NULL
were	NULL
thawed	NULL
,	NULL
diluted	NULL
in	NULL
MCDB131	NULL
medium	NULL
,	NULL
and	NULL
inoculated	NULL
onto	NULL
HUVEC	NULL
or	NULL
HAEC	NULL
grown	NULL
in	NULL
24-	NULL
or	NULL
96-well	NULL
tissue	NULL
4835	NULL
culture	NULL
plates	NULL
.	NULL

Plates	NULL
were	NULL
centrifuged	NULL
at	NULL
800	NULL
X	NULL
g	NULL
for	NULL
1	NULL
h	NULL
at	NULL
35°C	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
replaced	NULL
by	NULL
fresh	NULL
medium	NULL
and	NULL
plates	NULL
were	NULL
processed	NULL
for	NULL
additional	NULL
experiments	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Cell	NULL
surface	NULL
ELISA	NULL
for	NULL
P-selectin	NULL
,	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1-expression	NULL
Expression	NULL
of	NULL
different	NULL
adhesion	NULL
molecules	NULL
on	NULL
monolayer	NULL
,	NULL
of	NULL
endothelial	NULL
cells	NULL
preincubated	NULL
with	NULL
C.	NULL
preumonice	NULL
was	NULL
determined	NULL
by	NULL
cell	NULL
surface	NULL
ELISA	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Leukocyte	NULL
rolling	NULL
and	NULL
adhesion	NULL
assay	NULL
Leukocyte	NULL
rolling	NULL
and	NULL
adhesion	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
parallel	NULL
plate	NULL
flow	NULL
chamber	NULL
according	NULL
to	NULL
Lawrence	NULL
and	NULL
Springer	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Confluent	NULL
endothelial	NULL
monolayer	NULL
were	NULL
preincubated	NULL
with	NULL
C.	NULL
preumonice	NULL
.	NULL

A	NULL
suspension	NULL
of	NULL
10°	NULL
leukocytes/ml	NULL
was	NULL
perfused	NULL
through	NULL
the	NULL
chamber	NULL
at	NULL
a	NULL
constant	NULL
wall	NULL
shear	NULL
stress	NULL
of	NULL
1.0	NULL
dyne/cm*	NULL
(	NULL
syringe	NULL
pump	NULL
sp100i	NULL
;	NULL
World	NULL
Precision	NULL
In-struments	NULL
,	NULL
Sarasota	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Interactions	NULL
were	NULL
visualized	NULL
using	NULL
a	NULL
phase	NULL
contrast	NULL
video	NULL
microscope	NULL
(	NULL
IMT-2	NULL
;	NULL
Olympus	NULL
Optical	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
,	NULL
with	NULL
a	NULL
KP-C551	NULL
CCD	NULL
camera	NULL
;	NULL
Hitachi	NULL
,	NULL
Rodgau	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
videotaped	NULL
(	NULL
JVC	NULL
HR-57000	NULL
;	NULL
JVC	NULL
,	NULL
Friedberg	NULL
,	NULL
Germany	NULL
)	NULL
the	NULL
entire	NULL
time	NULL
period	NULL
of	NULL
leukocyte	NULL
perfusion	NULL
.	NULL

Rolling	NULL
in	NULL
the	NULL
parallel	NULL
plate	NULL
flow	NULL
chamber	NULL
was	NULL
measured	NULL
in	NULL
five	NULL
high	NULL
power	NULL
fields	NULL
for	NULL
each	NULL
experiment	NULL
.	NULL

Images	NULL
were	NULL
recorded	NULL
at	NULL
real	NULL
time	NULL
and	NULL
played	NULL
back	NULL
at	NULL
six-	NULL
or	NULL
ninefold	NULL
slower	NULL
speed	NULL
.	NULL

The	NULL
tape	NULL
was	NULL
paused	NULL
to	NULL
mark	NULL
the	NULL
location	NULL
of	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
displacement	NULL
of	NULL
the	NULL
center	NULL
of	NULL
individual	NULL
cells	NULL
was	NULL
measured	NULL
2-4	NULL
s	NULL
later	NULL
.	NULL

``	NULL
Rolling	NULL
``	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
number	NULL
of	NULL
rolling	NULL
cells/high	NULL
power	NULL
field	NULL
(	NULL
20	NULL
%	NULL
objective	NULL
)	NULL
during	NULL
a	NULL
3-min	NULL
observation	NULL
period	NULL
.	NULL

Leukocytes	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
adherent	NULL
after	NULL
30	NULL
s	NULL
of	NULL
stable	NULL
contact	NULL
with	NULL
the	NULL
monolayer	NULL
.	NULL

Adhesion	NULL
was	NULL
determined	NULL
after	NULL
5	NULL
min	NULL
of	NULL
perfusion	NULL
by	NULL
analysis	NULL
of	NULL
10	NULL
random	NULL
high	NULL
power	NULL
fields	NULL
(	NULL
20	NULL
%	NULL
)	NULL
from	NULL
videotape	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
rolling	NULL
or	NULL
adherent	NULL
cells/high	NULL
power	NULL
field	NULL
.	NULL

Leukocyte	NULL
transmigration	NULL
assay	NULL
For	NULL
transmigration	NULL
assays	NULL
,	NULL
HUVEC	NULL
were	NULL
grown	NULL
on	NULL
polycarbonat-mem-branes	NULL
(	NULL
6.5-mm	NULL
Trans-well	NULL
cell-culture	NULL
inserts	NULL
,	NULL
8-m	NULL
pore	NULL
size	NULL
;	NULL
Corning-Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
10°	NULL
2	NULL
'	NULL
7'-bis-	NULL
(	NULL
carboxyethy1	NULL
)	NULL
-5	NULL
(	NULL
6	NULL
)	NULL
-carboxy-fluorescein-acetoxymethylester-labeled	NULL
leukocytes	NULL
(	NULL
1	NULL
pM	NULL
,	NULL
15	NULL
min	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
upper	NULL
chamber	NULL
of	NULL
the	NULL
C.	NULL
prewmoniae-preincubated	NULL
HUVEC	NULL
monolayer	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Fluorescence	NULL
intensity	NULL
in	NULL
the	NULL
lower	NULL
compartment	NULL
was	NULL
quantitated	NULL
with	NULL
a	NULL
FluoroMax2/MicroMax	NULL
(	NULL
Instru-ments	NULL
S.A.	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
represented	NULL
migrated	NULL
leukocytes	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
For	NULL
detection	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
HUVEC	NULL
or	NULL
HAEC	NULL
grown	NULL
on	NULL
six-well	NULL
culture	NULL
plates	NULL
were	NULL
stimulated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
C.	NULL
preu-moniae	NULL
.	NULL

Cell	NULL
proteins	NULL
(	NULL
40	NULL
ug/lane	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
according	NULL
to	NULL
Laemmli	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
,	NULL
blotted	NULL
on	NULL
Hybond	NULL
enhanced	NULL
chemiluminescence	NULL
membranes	NULL
(	NULL
Amersham	NULL
,	NULL
Dreieich	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
blocked	NULL
,	NULL
incubated	NULL
with	NULL
rabbit-mAb	NULL
against	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
(	NULL
RC20	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
Kentucky	NULL
)	NULL
or	NULL
phosphorylated	NULL
p42/p44	NULL
MAPK	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
After	NULL
stimulation	NULL
with	NULL
6.5	NULL
X	NULL
10+	NULL
IFU/ml	NULL
C.	NULL
pneumoniae	NULL
for	NULL
different	NULL
time	NULL
points	NULL
,	NULL
nuclear	NULL
protein	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
by	NULL
Newton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
NF-KB	NULL
oligonucleotide	NULL
(	NULL
5'-AGT	NULL
TGA	NULL
GGG	NULL
GAC	NULL
TTT	NULL
CCC	NULL
AGG-3	NULL
'	NULL
)	NULL
(	NULL
Promega	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y	NULL
``	NULL
PJATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Bioline	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Unincorporated	NULL
nucleotides	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
Sephadex	NULL
G-25	NULL
spun	NULL
column	NULL
(	NULL
Pharmacia	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

EMSA	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
by	NULL
first	NULL
preincubating	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.7	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Approximately	NULL
10,000	NULL
cpm	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
of	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
was	NULL
then	NULL
added	NULL
and	NULL
allowed	NULL
to	NULL
bind	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
7	NULL
%	NULL
native	NULL
acryl-amide	NULL
gels	NULL
before	NULL
vacuum	NULL
drying	NULL
and	NULL
exposing	NULL
to	NULL
a	NULL
storage	NULL
phosphor	NULL
screen	NULL
for	NULL
quantification	NULL
and	NULL
documentation	NULL
(	NULL
PhosporImager	NULL
,	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
as	NULL
above	NULL
except	NULL
that	NULL
100-fold	NULL
excess	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
incubations	NULL
.	NULL

Immunofluorescence	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
After	NULL
stimulation	NULL
of	NULL
HUVEC	NULL
grown	NULL
on	NULL
glass	NULL
chamber	NULL
slides	NULL
(	NULL
Falcon	NULL
Cul-tureSlide	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Rutherford	NULL
,	NULL
NJ	NULL
)	NULL
with	NULL
6.5	NULL
X	NULL
104	NULL
IFU/ml	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4836	NULL
C.	NULL
pneumoniae	NULL
for	NULL
30	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
and	NULL
permeabilized	NULL
with	NULL
acetone/methanol	NULL
(	NULL
-20°C	NULL
,	NULL
50:50	NULL
v/v	NULL
)	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Human	NULL
Ig	NULL
was	NULL
used	NULL
to	NULL
reduce	NULL
nonspecific	NULL
binding	NULL
,	NULL
and	NULL
the	NULL
primary	NULL
Ab	NULL
(	NULL
polyclonal	NULL
rabbit	NULL
anti-human	NULL
NF-KB	NULL
p65	NULL
Ab	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
added	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Thereafter	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
thrice	NULL
and	NULL
exposed	NULL
to	NULL
an	NULL
ALEXA-488-conjugated	NULL
goat	NULL
anti-rabbit	NULL
Ig	NULL
Ab	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
washing	NULL
thrice	NULL
with	NULL
PBS	NULL
,	NULL
coverslips	NULL
were	NULL
sealed	NULL
and	NULL
examined	NULL
in	NULL
a	NULL
Olympus	NULL
IMT-2	NULL
fluorescence	NULL
microscope	NULL
(	NULL
Olympus	NULL
Optical	NULL
,	NULL
equipped	NULL
with	NULL
an	NULL
Olympus	NULL
OM-4	NULL
camera	NULL
)	NULL
with	NULL
an	NULL
Olympus	NULL
60	NULL
%	NULL
objective	NULL
.	NULL

NF-KB	NULL
reporter	NULL
gene	NULL
assay	NULL
Six	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
sites	NULL
(	NULL
5-GGG	NULL
GAC	NULL
TTT	NULL
CCC	NULL
T-3	NULL
'	NULL
;	NULL
italics	NULL
indicates	NULL
original	NULL
binding	NULL
site	NULL
)	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
in	NULL
a	NULL
pGL3basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Downstream	NULL
of	NULL
this	NULL
six	NULL
NF-KB	NULL
binding	NULL
re-gion	NULL
,	NULL
a	NULL
minimal	NULL
B-globin	NULL
promoter	NULL
(	NULL
containing	NULL
a	NULL
TATA	NULL
box	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
XhoU/HindIHI	NULL
sites	NULL
followed	NULL
by	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
pGL3.BG.6	NULL
«	NULL
B	NULL
)	NULL
.	NULL

HUVEC	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
2	NULL
ug	NULL
NF-KB	NULL
plasmid	NULL
using	NULL
SuperFect	NULL
transfection	NULL
reagent	NULL
(	NULL
Qiagen	NULL
,	NULL
Hilden	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Transfected	NULL
HUVEC	NULL
were	NULL
stimulated	NULL
,	NULL
harvested	NULL
in	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
and	NULL
total	NULL
protein	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
Bio-Rad	NULL
reagent	NULL
(	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Luciferase-assay	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Luminescence	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
Lumat	NULL
LB	NULL
9501	NULL
luminometer	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbad	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Relative	NULL
luminescence	NULL
readings	NULL
were	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
and	NULL
expressed	NULL
as	NULL
fold	NULL
activation	NULL
relative	NULL
to	NULL
control	NULL
+	NULL
SEM	NULL
.	NULL

A	NULL
control	NULL
plasmid	NULL
was	NULL
created	NULL
by	NULL
inserting	NULL
six	NULL
mutated	NULL
NK-KB	NULL
sites	NULL
(	NULL
5-GGC	NULL
CAC	NULL
TTT	NULL
CCC	NULL
T-3	NULL
'	NULL
;	NULL
italics	NULL
indicates	NULL
changes/mu-tation	NULL
compared	NULL
to	NULL
the	NULL
nonmutated	NULL
binding	NULL
site	NULL
)	NULL
into	NULL
the	NULL
same	NULL
vector	NULL
(	NULL
pGL3.BG.6	NULL
«	NULL
B.mut	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
guanidinium	NULL
isothiocyanate	NULL
method	NULL
as	NULL
described	NULL
by	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
(	NULL
36	NULL
)	NULL
.	NULL

cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-P	NULL
]	NULL
dCTP	NULL
(	NULL
>	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
by	NULL
random	NULL
priming	NULL
(	NULL
Rediprime	NULL
DNA	NULL
labeling	NULL
system	NULL
;	NULL
Amersham	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
added	NULL
to	NULL
the	NULL
pre-hybridization	NULL
chambers	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
12-16	NULL
h	NULL
at	NULL
42°C	NULL
.	NULL

E-selectin	NULL
and	NULL
VCAM-1	NULL
cDNA	NULL
probes	NULL
were	NULL
a	NULL
friendly	NULL
gift	NULL
of	NULL
Dr.	NULL
D.	NULL
Simmons	NULL
(	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Ox-ford	NULL
,	NULL
U.K.	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ICAM-1	NULL
probe	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
D.	NULL
Vestweber	NULL
(	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Miinster	NULL
,	NULL
Miinster	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
598-bp	NULL
cDNA	NULL
fragment	NULL
of	NULL
GAPDH	NULL
was	NULL
obtained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Statistical	NULL
methods	NULL
Depending	NULL
on	NULL
the	NULL
number	NULL
of	NULL
groups	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
number	NULL
of	NULL
different	NULL
time	NULL
points	NULL
studied	NULL
(	NULL
B	NULL
)	NULL
,	NULL
data	NULL
of	NULL
Figs	NULL
.	NULL

1b	NULL
and	NULL
2	NULL
,	NULL
a	NULL
,	NULL
c	NULL
,	NULL
and	NULL
e	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
two-way	NULL
ANOVA	NULL
.	NULL

An	NULL
one-way	NULL
ANOVA	NULL
was	NULL
used	NULL
for	NULL
data	NULL
of	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
a	NULL
and	NULL
c	NULL
,	NULL
2	NULL
,	NULL
b	NULL
,	NULL
d	NULL
,	NULL
and	NULL
f	NULL
,	NULL
3	NULL
,	NULL
a-c	NULL
,	NULL
and	NULL
4b	NULL
.	NULL

Values	NULL
of	NULL
p	NULL
<	NULL
0.05	NULL
were	NULL
considered	NULL
significant	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Results	NULL
C.	NULL
pneumoniae	NULL
strain	NULL
GiD	NULL
infects	NULL
human	NULL
endothelial	NULL
cells	NULL
C.	NULL
pneumoniae	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
infect	NULL
and	NULL
thereby	NULL
activate	NULL
human	NULL
endothelial	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
39	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
leukocyte-endothelial	NULL
cell	NULL
interaction	NULL
,	NULL
we	NULL
infected	NULL
HUVEC	NULL
with	NULL
the	NULL
recently	NULL
described	NULL
C.	NULL
pneumoniae	NULL
strain	NULL
GiD	NULL
(	NULL
31	NULL
)	NULL
.	NULL

GiD	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
a	NULL
highly	NULL
effective	NULL
Chlamydia	NULL
strain	NULL
and	NULL
was	NULL
able	NULL
to	NULL
replicate	NULL
and	NULL
to	NULL
form	NULL
inclusions	NULL
in	NULL
HUVEC	NULL
with	NULL
a	NULL
mean	NULL
titer	NULL
of	NULL
2.6	NULL
X	NULL
10°	NULL
IFU/ml	NULL
as	NULL
compared	NULL
with	NULL
growth	NULL
in	NULL
cyclohexamide-treated	NULL
HEp-2	NULL
cells	NULL
at	NULL
a	NULL
mean	NULL
titer	NULL
of	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
.	NULL

Inclusions	NULL
were	NULL
visualized	NULL
using	NULL
a	NULL
FITC-conjugated	NULL
genus-specific	NULL
mAb	NULL
(	NULL
Chlamydia	NULL
FIGURE	NULL
1	NULL
.	NULL

Infection	NULL
of	NULL
endothelial	NULL
cells	NULL
increased	NULL
monocyte	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transendothelial	NULL
migration	NULL
.	NULL

a	NULL
,	NULL
Endothelial	NULL
cells	NULL
grown	NULL
on	NULL
Thermanox	NULL
coverslips	NULL
were	NULL
infected	NULL
with	NULL
C.	NULL
preumoniae	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

After	NULL
4	NULL
h	NULL
,	NULL
coverslips	NULL
were	NULL
processed	NULL
for	NULL
laminar	NULL
flow	NULL
assay	NULL
.	NULL

A	NULL
total	NULL
of	NULL
3	NULL
X	NULL
10°	NULL
monocytes/ml	NULL
was	NULL
injected	NULL
into	NULL
the	NULL
flow	NULL
system	NULL
and	NULL
perfused	NULL
over	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
for	NULL
5	NULL
min	NULL
using	NULL
a	NULL
high	NULL
precision	NULL
syringe	NULL
pump	NULL
.	NULL

Rolling	NULL
monocytes	NULL
(	NULL
for	NULL
definition	NULL
and	NULL
details	NULL
,	NULL
see	NULL
ENDOTHELIAL	NULL
CELL	NULL
INFECTION	NULL
WITH	NULL
Chlamydia	NULL
pneumoniae	NULL
1607	NULL
mAb	NULL
against	NULL
T	NULL
e	NULL
a	NULL
®	NULL
a	NULL
xP	NULL
Z	NULL
1404	NULL
C	NULL
oS	NULL
C	NULL
@	NULL
f	NULL
P	NULL
C	NULL
8	NULL
0	NULL
B	NULL
o	NULL
20	NULL
°o	NULL
G	NULL
8	NULL
.	NULL

120-4	NULL
o	NULL
C	NULL
4h	NULL
€	NULL
1004	NULL
HH	NULL
24h	NULL
£	NULL
pl	NULL
2	NULL
.	NULL

804	NULL
®	NULL
$	NULL
3	NULL
604	NULL
0	NULL
2	NULL
404	NULL
&	NULL
[	NULL
=	NULL
=	NULL
204	NULL
o	NULL
none	NULL
<	NULL
--	NULL
C.	NULL
pneumoniae	NULL
--	NULL
monocytes	NULL
PMN	NULL
507	NULL
504	NULL
b	NULL
6.5	NULL
x	NULL
10°	NULL
404	NULL
6.5	NULL
x	NULL
10°	NULL
404	NULL
304	NULL
304	NULL
6.5	NULL
x	NULL
10°	NULL
204	NULL
\r	NULL
20-4	NULL
6.5	NULL
x	NULL
10°	NULL
\I	NULL
adhesion	NULL
[	NULL
celis/high	NULL
power	NULL
field	NULL
]	NULL
104	NULL
104	NULL
no	NULL
C.	NULL
pneumoniae	NULL
no	NULL
C.	NULL
pneumoniae	NULL
M—	NULL
quer	NULL
Oi	NULL
~*	NULL
-+-	NULL
r-	NULL
--	NULL
0	NULL
4	NULL
12	NULL
24	NULL
72	NULL
0	NULL
4	NULL
12	NULL
24	NULL
72	NULL
incubation	NULL
time	NULL
[	NULL
h	NULL
]	NULL
107	NULL
C	NULL
8-	NULL
[	NULL
_	NULL
]	NULL
J4h	NULL
as	NULL
HM	NULL
24h	NULL
&	NULL
8	NULL
64	NULL
L-fo	NULL
2	NULL
€	NULL
2	NULL
4	NULL
C	NULL
E	NULL
2	NULL
0	NULL
mi	NULL
none	NULL
4	NULL
3	NULL
C.	NULL
pneumoniae	NULL
[	NULL
6.5x10*	NULL
IFU/mI	NULL
]	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
counted	NULL
over	NULL
a	NULL
3-min	NULL
observation	NULL
period	NULL
.	NULL

Note	NULL
that	NULL
monocyte	NULL
rolling	NULL
on	NULL
C.	NULL
preumoniae-infected	NULL
endothelial	NULL
cells	NULL
(	NULL
6.5	NULL
%	NULL
10+	NULL
IFU/ml	NULL
,	NULL
4	NULL
h	NULL
,	NULL
open	NULL
bars	NULL
and	NULL
24	NULL
h	NULL
,	NULL
filled	NULL
bars	NULL
)	NULL
at	NULL
a	NULL
shear	NULL
rate	NULL
of	NULL
1	NULL
dyne/cm*	NULL
was	NULL
significantly	NULL
increased	NULL
.	NULL

C.	NULL
preumoniae-mediated	NULL
rolling	NULL
after	NULL
4	NULL
h	NULL
was	NULL
reduced	NULL
by	NULL
anti-E-selectin	NULL
mAb	NULL
(	NULL
50	NULL
pg/ml	NULL
,	NULL
60	NULL
min	NULL
)	NULL
and	NULL
after	NULL
24	NULL
h	NULL
by	NULL
anti-VCAM-1	NULL
mAb	NULL
on	NULL
HUVEC	NULL
(	NULL
50	NULL
ug/ml	NULL
,	NULL
60	NULL
min	NULL
)	NULL
or	NULL
anti-CD49d	NULL
mAb	NULL
on	NULL
monocytes	NULL
(	NULL
10	NULL
ug/ml	NULL
,	NULL
10	NULL
min	NULL
}	NULL
.	NULL

b	NULL
,	NULL
C.	NULL
preumoniae-induced	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
monolayer	NULL
under	NULL
flow	NULL
conditions	NULL
.	NULL

Adhesion	NULL
was	NULL
determined	NULL
after	NULL
5	NULL
min	NULL
of	NULL
perfusion	NULL
by	NULL
analysis	NULL
of	NULL
10	NULL
random	NULL
high	NULL
power	NULL
fields	NULL
(	NULL
20	NULL
%	NULL
)	NULL
from	NULL
videotape	NULL
,	NULL
and	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
of	NULL
total	NULL
adherent	NULL
leukocytes	NULL
.	NULL

c	NULL
,	NULL
Note	NULL
that	NULL
endothelial	NULL
cell	NULL
infection	NULL
with	NULL
6.5	NULL
X	NULL
X	NULL
10°	NULL
IFU/ml	NULL
C.	NULL
pneumoniae	NULL
dose-dependently	NULL
increased	NULL
monocyte	NULL
transmigration	NULL
after	NULL
4	NULL
and	NULL
24	NULL
h.	NULL
Data	NULL
presented	NULL
(	NULL
a-c	NULL
)	NULL
are	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Modification	NULL
of	NULL
C.	NULL
pneumoniae-induced	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
HUVEC	NULL
by	NULL
mAbs	NULL
directed	NULL
against	NULL
different	NULL
adhesion	NULL
molecules	NULL
``	NULL
Percent	NULL
Inhibition	NULL
of	NULL
Adhesion	NULL
PMN	NULL
Monocytes	NULL
4	NULL
h	NULL
24	NULL
h	NULL
4	NULL
h	NULL
24	NULL
h	NULL
mAb	NULL
Added	NULL
incubation	NULL
incubation	NULL
incubation	NULL
incubation	NULL
Control®	NULL
4.0	NULL
+	NULL
2.0	NULL
3.0	NULL
+	NULL
1.7	NULL
3.2	NULL
+	NULL
1.2	NULL
24	NULL
+	NULL
1.1	NULL
CD1la	NULL
85.7	NULL
%	NULL
4.1	NULL
27.6	NULL
%	NULL
34	NULL
71.5	NULL
%	NULL
3.8	NULL
85.1	NULL
CD11b	NULL
60.9	NULL
+	NULL
1.8	NULL
56.3	NULL
+	NULL
1.9	NULL
55.9+	NULL
2.2	NULL
69.6	NULL
+	NULL
3.3	NULL
CD1le	NULL
36.5	NULL
+	NULL
7.2	NULL
7.3	NULL
*	NULL
22	NULL
17.8	NULL
+	NULL
3.5	NULL
3.5	NULL
+	NULL
0.8	NULL
CD18	NULL
95.5	NULL
+	NULL
5.6	NULL
60.6	NULL
+	NULL
3.6	NULL
68.8	NULL
+4.1	NULL
68.7	NULL
+	NULL
4.2	NULL
CD49d	NULL
22.1	NULL
+23	NULL
40.2	NULL
%	NULL
4.3	NULL
34.1	NULL
+34	NULL
56.8	NULL
£	NULL
3.3	NULL
E-selectin	NULL
45.5	NULL
+	NULL
2.2	NULL
5.3	NULL
+	NULL
1.5	NULL
58.3	NULL
+	NULL
3.6	NULL
9.3	NULL
+	NULL
1.7	NULL
ICAM-1	NULL
42.8	NULL
£	NULL
4.2	NULL
43.6	NULL
%	NULL
3.5	NULL
63.2	NULL
%	NULL
1.9	NULL
84.2+3.9	NULL
VCAM-1	NULL
3.3	NULL
+	NULL
0.9	NULL
24.2	NULL
%	NULL
14	NULL
28.5	NULL
+34	NULL
83.8	NULL
+25	NULL
``	NULL
HUVEC	NULL
on	NULL
glass	NULL
coverslips	NULL
were	NULL
incubated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
C.	NULL
preumoniae	NULL
for	NULL
4	NULL
or	NULL
24	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
exposed	NULL
to	NULL
50	NULL
ug/ml	NULL
mAb	NULL
against	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
or	NULL
VCAM-1	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
mounted	NULL
in	NULL
a	NULL
parallel	NULL
plate	NULL
flow	NULL
cham-ber	NULL
.	NULL

Then	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
leukocytes/ml	NULL
(	NULL
PMN	NULL
or	NULL
monocytes	NULL
)	NULL
were	NULL
perfused	NULL
at	NULL
a	NULL
wall	NULL
shear	NULL
stress	NULL
of	NULL
1.0	NULL
dyne/cm*	NULL
.	NULL

Alternatively	NULL
,	NULL
leukocytes	NULL
were	NULL
pretreated	NULL
with	NULL
mAb	NULL
against	NULL
B	NULL
;	NULL
or	NULL
B	NULL
,	NULL
integrins	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
added	NULL
to	NULL
C.	NULL
prewmonice-stimulated	NULL
HUVEC	NULL
.	NULL

Leukocyte	NULL
adhesion	NULL
to	NULL
C.	NULL
prewnoniae-infected	NULL
HUVEC	NULL
increased	NULL
after	NULL
1	NULL
h	NULL
and	NULL
remained	NULL
elevated	NULL
up	NULL
72	NULL
h.	NULL
Data	NULL
are	NULL
indicated	NULL
as	NULL
percent	NULL
inhibition	NULL
of	NULL
adherent	NULL
leuko-cytes/mm*	NULL
+	NULL
SEM	NULL
(	NULL
r	NULL
=	NULL
5	NULL
)	NULL
.	NULL

*	NULL
Use	NULL
of	NULL
nonspecific	NULL
IgG-isotype	NULL
control	NULL
.	NULL

culture	NULL
confirmation	NULL
system	NULL
;	NULL
Sanofi	NULL
Diagnostics	NULL
Pasteur	NULL
,	NULL
Freiburg	NULL
,	NULL
Germany	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

C.	NULL
pneumoniae-mediated	NULL
leukocyte	NULL
endothelial	NULL
cell	NULL
interaction	NULL
To	NULL
investigate	NULL
C.	NULL
preumoniae-mediated	NULL
leukocyte-endothelial	NULL
cell	NULL
interaction	NULL
,	NULL
HUVEC	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
strain	NULL
GiD	NULL
.	NULL

Intracellular	NULL
infection	NULL
resulted	NULL
in	NULL
a	NULL
profound	NULL
cell	NULL
activation	NULL
with	NULL
subsequently	NULL
enhanced	NULL
leukocyte	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transmigration	NULL
.	NULL

Inactivation	NULL
of	NULL
bacterial	NULL
LPS	NULL
by	NULL
pretreatment	NULL
of	NULL
C.	NULL
pneumoniae	NULL
with	NULL
polymyxin	NULL
B	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
leukocyte-HUVEC	NULL
interaction	NULL
.	NULL

Killing	NULL
of	NULL
C.	NULL
pneumoniae	NULL
by	NULL
heating	NULL
(	NULL
90°C	NULL
,	NULL
60	NULL
min	NULL
)	NULL
reduced	NULL
chlamydial-mediated	NULL
effects	NULL
almost	NULL
completely	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Monocyte	NULL
rolling	NULL
on	NULL
the	NULL
C.	NULL
preumoniae-infected	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
was	NULL
significantly	NULL
increased	NULL
after	NULL
4	NULL
h	NULL
and	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

la	NULL
)	NULL
.	NULL

Leukocyte	NULL
rolling	NULL
after	NULL
4	NULL
h	NULL
was	NULL
reduced	NULL
by	NULL
a	NULL
mAb	NULL
against	NULL
endothelial	NULL
E-selectin	NULL
(	NULL
56	NULL
%	NULL
)	NULL
.	NULL

mAb	NULL
directed	NULL
against	NULL
CD11b/18	NULL
or	NULL
CD49d	NULL
on	NULL
monocytes	NULL
and	NULL
VCAM-1	NULL
on	NULL
endothelial	NULL
cells	NULL
were	NULL
ineffective	NULL
at	NULL
that	NULL
time	NULL
point	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
C.	NULL
pneumoniae	NULL
infection	NULL
,	NULL
preincubation	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
anti-VCAM-1	NULL
as	NULL
well	NULL
as	NULL
monocytes	NULL
with	NULL
anti-CD49d	NULL
diminished	NULL
leukocyte	NULL
rolling	NULL
by	NULL
55	NULL
and	NULL
70	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
whereas	NULL
Abs	NULL
directed	NULL
against	NULL
CD11b/18	NULL
or	NULL
E-selectin	NULL
were	NULL
ineffective	NULL
.	NULL

Furthermore	NULL
,	NULL
intracellular	NULL
infection	NULL
of	NULL
HUVEC	NULL
dose-	NULL
and	NULL
time-dependently	NULL
increased	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
with	NULL
maximal	NULL
effects	NULL
seen	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
.	NULL

Adhesion	NULL
increased	NULL
after	NULL
2	NULL
h	NULL
and	NULL
remained	NULL
elevated	NULL
up	NULL
to	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

16	NULL
,	NULL
left	NULL
,	NULL
monocytes	NULL
;	NULL
right	NULL
,	NULL
PMN	NULL
)	NULL
.	NULL

After	NULL
4	NULL
h	NULL
of	NULL
HUVEC	NULL
incubation	NULL
with	NULL
C.	NULL
preumoniae	NULL
,	NULL
PMN	NULL
and	NULL
monocyte	NULL
adherence	NULL
was	NULL
reduced	NULL
by	NULL
anti-E-selectin	NULL
(	NULL
45.5	NULL
and	NULL
58.3	NULL
%	NULL
)	NULL
and	NULL
anti-ICAM-1	NULL
Abs	NULL
(	NULL
42.8	NULL
and	NULL
63.2	NULL
%	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Monocyte	NULL
adhesion	NULL
was	NULL
also	NULL
diminished	NULL
by	NULL
an	NULL
anti-VCAM-1	NULL
mAb	NULL
(	NULL
28.5	NULL
%	NULL
)	NULL
.	NULL

Anti-B	NULL
,	NULL
(	NULL
VLA	NULL
,	NULL
)	NULL
and	NULL
B	NULL
,	NULL
integrin	NULL
Abs	NULL
reduced	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
C.	NULL
preumoniae-stimulated	NULL
endothelial	NULL
cells	NULL
by	NULL
up	NULL
to	NULL
90	NULL
%	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
for	NULL
details	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
C.	NULL
preumoniae-infected	NULL
HUVEC	NULL
was	NULL
reduced	NULL
by	NULL
an	NULL
anti-ICAM-1	NULL
Ab	NULL
(	NULL
43.6	NULL
%	NULL
for	NULL
PMN	NULL
and	NULL
84.2	NULL
%	NULL
for	NULL
monocytes	NULL
)	NULL
and	NULL
an	NULL
anti-	NULL
VCAM-1	NULL
mAb	NULL
(	NULL
24.2	NULL
and	NULL
83.8	NULL
%	NULL
4837	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Modification	NULL
of	NULL
C.	NULL
pneumoniae-induced	NULL
monocyte	NULL
transmigration	NULL
through	NULL
the	NULL
HUVEC	NULL
monolayer	NULL
by	NULL
mAbs	NULL
directed	NULL
against	NULL
different	NULL
adhesion	NULL
molecules	NULL
``	NULL
Percent	NULL
Inhibition	NULL
of	NULL
Transmigration	NULL
mAb	NULL
Added	NULL
4	NULL
h	NULL
incubation	NULL
24	NULL
h	NULL
incubation	NULL
Control	NULL
``	NULL
1.3	NULL
+	NULL
0.7	NULL
0.7	NULL
+	NULL
0.2	NULL
CD11b	NULL
62.3	NULL
+	NULL
5.2	NULL
704	NULL
+	NULL
3.7	NULL
CD18	NULL
80.1	NULL
+	NULL
4.4	NULL
85.2	NULL
+	NULL
5.2	NULL
CD11b	NULL
+	NULL
CD18	NULL
88.4	NULL
+	NULL
5.3	NULL
90.5	NULL
+	NULL
4.3	NULL
E-selectin	NULL
12.2	NULL
+	NULL
1.2	NULL
0.3	NULL
+	NULL
0.1	NULL
ICAM-1	NULL
55.3	NULL
+	NULL
4.2	NULL
47.5	NULL
+	NULL
3.3	NULL
VCAM-1	NULL
1.3	NULL
+	NULL
0.5	NULL
2.1	NULL
+	NULL
0.7	NULL
PECAM-1	NULL
50.9	NULL
+	NULL
3.5	NULL
44.6	NULL
+	NULL
4.8	NULL
``	NULL
HUVEC	NULL
grown	NULL
on	NULL
polycarbonate	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
TFU/ml	NULL
C.	NULL
pneumoniae	NULL
strain	NULL
GD	NULL
for	NULL
4	NULL
or	NULL
24	NULL
h	NULL
as	NULL
described	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
exposed	NULL
to	NULL
50	NULL
ug/ml	NULL
mAb	NULL
against	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
or	NULL
VCAM-1	NULL
for	NULL
1	NULL
h.	NULL
Then	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
monocytes	NULL
were	NULL
added	NULL
to	NULL
the	NULL
upper	NULL
chamber	NULL
and	NULL
allowed	NULL
to	NULL
transmigrate	NULL
for	NULL
2	NULL
h.	NULL
Alternatively	NULL
,	NULL
monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
mAb	NULL
against	NULL
CD11b	NULL
and/or	NULL
CD18	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
added	NULL
to	NULL
C.	NULL
prewmonice-stimulated	NULL
HUVEC	NULL
.	NULL

Transmigration	NULL
through	NULL
the	NULL
C.	NULL
preumoniae-infected	NULL
HUVEC	NULL
monolayer	NULL
increased	NULL
dose-dependently	NULL
.	NULL

Data	NULL
are	NULL
indicated	NULL
as	NULL
percent	NULL
inhibition	NULL
of	NULL
monocyte	NULL
transmigration	NULL
+	NULL
SEM	NULL
(	NULL
7	NULL
=	NULL
5	NULL
)	NULL
.	NULL

*	NULL
Use	NULL
of	NULL
nonspecific	NULL
IgG-isotype	NULL
control	NULL
.	NULL

for	NULL
PMN	NULL
and	NULL
monocytes	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
whereas	NULL
Abs	NULL
directed	NULL
against	NULL
E-selectin	NULL
were	NULL
ineffective	NULL
.	NULL

Preincubation	NULL
of	NULL
leukocytes	NULL
with	NULL
mAb	NULL
against	NULL
B	NULL
,	NULL
(	NULL
VLA	NULL
,	NULL
)	NULL
and	NULL
3	NULL
,	NULL
integrins	NULL
also	NULL
decreased	NULL
PMN	NULL
and	NULL
monocyte	NULL
adhesion	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Monocyte	NULL
adhesion	NULL
to	NULL
C.	NULL
HUVEC	NULL
was	NULL
followed	NULL
by	NULL
a	NULL
subsequent	NULL
dose-	NULL
and	NULL
time-dependently	NULL
enhanced	NULL
transendothelial	NULL
migration	NULL
(	NULL
Fig	NULL
.	NULL

1c	NULL
)	NULL
.	NULL

This	NULL
parameter	NULL
showed	NULL
a	NULL
similar	NULL
inhibitory	NULL
profile	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
different	NULL
mAb	NULL
used	NULL
(	NULL
for	NULL
details	NULL
,	NULL
see	NULL
Table	NULL
ID	NULL
)	NULL
.	NULL

C.	NULL
pneumoniae	NULL
increased	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
Cell	NULL
surface	NULL
ELISA	NULL
for	NULL
endothelial	NULL
adhesion	NULL
molecule	NULL
expression	NULL
was	NULL
performed	NULL
to	NULL
further	NULL
characterize	NULL
C.	NULL
pneumoniae-mediated	NULL
leukocyte-endothelial	NULL
cell	NULL
interaction	NULL
.	NULL

Infection	NULL
of	NULL
HUVEC	NULL
and	NULL
HAEC	NULL
with	NULL
C.	NULL
pneumoniae	NULL
dose-	NULL
and	NULL
time-dependently	NULL
increased	NULL
expression	NULL
of	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
on	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVEC	NULL
and	NULL
HAEC	NULL
)	NULL
.	NULL

Maximal	NULL
effects	NULL
in	NULL
this	NULL
study	NULL
occurred	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
6.5	NULL
X	NULL
10*	NULL
IFU/ml	NULL
(	NULL
HAEC	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

E-selectin	NULL
expression	NULL
in	NULL
C.	NULL
preumoniae-stimulated	NULL
endothelial	NULL
cells	NULL
increased	NULL
2	NULL
h	NULL
postinfection	NULL
,	NULL
peaked	NULL
at	NULL
4	NULL
h	NULL
,	NULL
and	NULL
declined	NULL
to	NULL
almost	NULL
baseline	NULL
after	NULL
18-24	NULL
h.	NULL
Even	NULL
the	NULL
lowest	NULL
Chlamydia	NULL
concentration	NULL
tested	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
a	NULL
significant	NULL
E-selectin	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

ICAM-1	NULL
and	NULL
VCAM-1	NULL
surface	NULL
expression	NULL
in	NULL
C.	NULL
pneumoniae	NULL
stimulated	NULL
cells	NULL
increased	NULL
4-8	NULL
h	NULL
postinfection	NULL
,	NULL
peaked	NULL
at	NULL
12-24	NULL
h	NULL
(	NULL
HUVEC	NULL
)	NULL
and	NULL
persisted	NULL
up	NULL
to	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
c	NULL
and	NULL
e	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
HUVEC	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
the	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
response	NULL
in	NULL
HAEC	NULL
were	NULL
delayed	NULL
,	NULL
and	NULL
absolute	NULL
levels	NULL
of	NULL
protein	NULL
expression	NULL
diminished	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
C.	NULL
pneumoniae-pretreated	NULL
HUVEC	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
verify	NULL
mRNA	NULL
up-regulation	NULL
for	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

E-selectin	NULL
mRNA	NULL
peaked	NULL
at	NULL
2	NULL
h	NULL
of	NULL
C.	NULL
preumoniae	NULL
stimulation	NULL
and	NULL
almost	NULL
completely	NULL
disappeared	NULL
after	NULL
8	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

ICAM-1	NULL
and	NULL
VCAM-1	NULL
mRNA	NULL
peaked	NULL
at	NULL
2	NULL
h	NULL
,	NULL
declined	NULL
to	NULL
almost	NULL
baseline	NULL
after	NULL
8	NULL
h	NULL
,	NULL
and	NULL
was	NULL
detectable	NULL
again	NULL
after	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4838	NULL
0.45	NULL
0.4	NULL
0.40	NULL
b	NULL
0	NULL
.	NULL

35	NULL
0.3	NULL
0.30	NULL
0.25	NULL
0.20	NULL
0.2	NULL
0.15	NULL
0.107	NULL
law	NULL
0.1	NULL
``	NULL
0	NULL
4	NULL
8	NULL
12	NULL
24	NULL
72	NULL
none	NULL
4	NULL
3	NULL
2	NULL
1	NULL
mo	NULL
4.1	NULL
1.1	NULL
€	NULL
S	NULL
d	NULL
ad	NULL
o	NULL
0.9	NULL
0.9	NULL
<	NULL
t	NULL
waa	NULL
&	NULL
or	NULL
0.7	NULL
A	NULL
&	NULL
$	NULL
os	NULL
0.5	NULL
E	NULL
g	NULL
0.3	NULL
**	NULL
none	NULL
4	NULL
3	NULL
2	NULL
1	NULL
o	NULL
0.6	NULL
0.6	NULL
0.5	NULL
0.5	NULL
0.4	NULL
0.4	NULL
0.3	NULL
0.3	NULL
0.2	NULL
0.2	NULL
0.19	NULL
1	NULL
0	NULL
none	NULL
4	NULL
3	NULL
°	NULL
204	NULL
C.	NULL
pneumoniae	NULL
[	NULL
6.5x10*	NULL
IFU/m	NULL
{	NULL
i	NULL
]	NULL
loused	NULL
24	NULL
72	NULL
0	NULL
4	NULL
8	NULL
12	NULL
incubation	NULL
time	NULL
[	NULL
h	NULL
]	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Endothelial	NULL
adhesion	NULL
molecules	NULL
,	NULL
quantitated	NULL
by	NULL
cell	NULL
surface	NULL
ELISA	NULL
,	NULL
were	NULL
dose-	NULL
and	NULL
time-dependently	NULL
up-regulated	NULL
in	NULL
C.	NULL
preumoniae-stimulated	NULL
HUVEC	NULL
(	NULL
-	NULL
)	NULL
and	NULL
HAEC	NULL
(	NULL
@	NULL
-	NULL
@	NULL
)	NULL
.	NULL

E-selectin	NULL
expression	NULL
peaked	NULL
at	NULL
4	NULL
h	NULL
(	NULL
a	NULL
)	NULL
,	NULL
and	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
expression	NULL
peaked	NULL
at	NULL
12-24	NULL
h	NULL
in	NULL
HUVEC	NULL
and	NULL
at	NULL
>	NULL
72	NULL
h	NULL
in	NULL
HAEC	NULL
(	NULL
c	NULL
and	NULL
e	NULL
)	NULL
.	NULL

Even	NULL
the	NULL
lowest	NULL
Chlamydiae	NULL
concentration	NULL
tested	NULL
(	NULL
6.5	NULL
X	NULL
10	NULL
'	NULL
IFU/ml	NULL
)	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
significant	NULL
E-selectin	NULL
response	NULL
in	NULL
HUVEC	NULL
after	NULL
4	NULL
h	NULL
(	NULL
b	NULL
)	NULL
.	NULL

Dose-dependent	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
expression	NULL
was	NULL
determined	NULL
at	NULL
12	NULL
h	NULL
(	NULL
d	NULL
and	NULL
f	NULL
)	NULL
.	NULL

Open	NULL
symbols	NULL
(	NULL
a	NULL
,	NULL
c	NULL
,	NULL
and	NULL
e	NULL
)	NULL
or	NULL
bars	NULL
(	NULL
b	NULL
,	NULL
d	NULL
,	NULL
and	NULL
f	NULL
)	NULL
indicate	NULL
unstimulated	NULL
endothelial	NULL
cells	NULL
.	NULL

Data	NULL
presented	NULL
(	NULL
a-f	NULL
)	NULL
are	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

Role	NULL
of	NULL
NF-KB	NULL
in	NULL
C.	NULL
pneumoniae-mediated	NULL
endothelial	NULL
cell	NULL
activation	NULL
Previous	NULL
studies	NULL
have	NULL
elaborated	NULL
the	NULL
importance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activities	NULL
of	NULL
the	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
genes	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Multiple	NULL
NF-kB	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
located	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
all	NULL
three	NULL
genes	NULL
(	NULL
41-43	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
C.	NULL
preumoniqe-infected	NULL
endothelial	NULL
cells	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
enhanced	NULL
binding-capacity	NULL
of	NULL
NF-KB	NULL
to	NULL
corresponding	NULL
consensus	NULL
oligonucleotides	NULL
using	NULL
band	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

This	NULL
point	NULL
was	NULL
verified	NULL
by	NULL
immunofluorescence	NULL
,	NULL
which	NULL
indicated	NULL
increased	NULL
NF-KB	NULL
translocation	NULL
within	NULL
15-30	NULL
min	NULL
of	NULL
C.	NULL
pneumoniae	NULL
stimulation	NULL
with	NULL
maximal	NULL
effects	NULL
after	NULL
30	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4¢	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
confirmed	NULL
by	NULL
enhanced	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
of	NULL
a	NULL
luciferase-gene	NULL
transiently	NULL
transfected	NULL
into	NULL
HUVEC	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

HUVEC	NULL
were	NULL
transiently	NULL
transfected	NULL
for	NULL
2	NULL
h	NULL
with	NULL
2	NULL
ug	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
plasmid	NULL
(	NULL
pGL3.BG.6kB	NULL
)	NULL
,	NULL
stimulated	NULL
,	NULL
and	NULL
harvested	NULL
in	NULL
reporter	NULL
lysis	NULL
buffer	NULL
after	NULL
4	NULL
h.	NULL
NF-KB	NULL
activity	NULL
(	NULL
indicated	NULL
as	NULL
chemiluminescence/ug	NULL
protein	NULL
)	NULL
increased	NULL
dose-dependently	NULL
in	NULL
C.	NULL
preumoniae-stimulated	NULL
endothelial	NULL
cells	NULL
.	NULL

Chla-mydia-stimulated	NULL
HUVEC	NULL
,	NULL
which	NULL
had	NULL
been	NULL
transiently	NULL
transfected	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
mutated	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
plasmid	NULL
ENDOTHELIAL	NULL
CELL	NULL
INFECTION	NULL
WITH	NULL
Chlamydia	NULL
pneumoniae	NULL
250	NULL
200	NULL
a	NULL
150	NULL
100	NULL
50	NULL
E-selectin	NULL
150	NULL
125	NULL
b	NULL
100	NULL
15	NULL
so	NULL
25	NULL
ICAM-1	NULL
100	NULL
so	NULL
C	NULL
so	NULL
40	NULL
20	NULL
ratio	NULL
mRNA/GAPDH	NULL
[	NULL
%	NULL
of	NULL
IL1f	NULL
stimulated	NULL
control	NULL
]	NULL
h	NULL
VCAM-1	NULL
GAPDH	NULL
0	NULL
8	NULL
240	NULL
40	NULL
20	NULL
4	NULL
O8	NULL
24	NULL
[	NULL
hj	NULL
control	NULL
IL1B	NULL
_C	NULL
.	NULL

pneumoniae	NULL
FIGURE	NULL
3	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
C.	NULL
pneumoniae	NULL
(	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/	NULL
ml	NULL
)	NULL
-infected	NULL
HUVEC	NULL
.	NULL

At	NULL
time	NULL
points	NULL
indicated	NULL
,	NULL
plates	NULL
were	NULL
washed	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

Bands	NULL
of	NULL
three	NULL
independent	NULL
blots	NULL
were	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
and	NULL
corrected	NULL
for	NULL
GAPDH	NULL
expression	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
IL1B-induced	NULL
mRNA	NULL
expression	NULL
after	NULL
4	NULL
h.	NULL
Note	NULL
that	NULL
E-selectin	NULL
(	NULL
a	NULL
)	NULL
,	NULL
ICAM-1	NULL
(	NULL
b	NULL
)	NULL
,	NULL
and	NULL
VCAM-1	NULL
mRNA	NULL
(	NULL
c	NULL
)	NULL
peaked	NULL
at	NULL
2	NULL
h	NULL
and	NULL
declined	NULL
to	NULL
almost	NULL
baseline	NULL
after	NULL
8	NULL
h.	NULL
ICAM-1	NULL
and	NULL
VCAM-1	NULL
mRNA	NULL
increased	NULL
again	NULL
after	NULL
24	NULL
h	NULL
(	NULL
b	NULL
and	NULL
c	NULL
)	NULL
.	NULL

(	NULL
pGL3.BG.6kB.mut	NULL
)	NULL
,	NULL
revealed	NULL
no	NULL
detectable	NULL
luciferase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

C.	NULL
pneumoniae	NULL
induced	NULL
rapid	NULL
total	NULL
protein	NULL
tyrosine	NULL
and	NULL
p42/p44	NULL
MAPK	NULL
phosphorylation	NULL
in	NULL
endothelial	NULL
cells	NULL
Activation	NULL
of	NULL
p42/p44	NULL
MAPK	NULL
isoforms	NULL
is	NULL
an	NULL
early	NULL
step	NULL
in	NULL
cell	NULL
activation	NULL
and	NULL
intracellular	NULL
signaling	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
showed	NULL
a	NULL
time-dependently	NULL
enhanced	NULL
total	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
)	NULL
,	NULL
specifically	NULL
of	NULL
phosphorylated	NULL
p42	NULL
and	NULL
p44	NULL
MAPK	NULL
isoforms	NULL
in	NULL
HUVEC	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
and	NULL
HAEC	NULL
(	NULL
Fig	NULL
.	NULL

5¢	NULL
)	NULL
.	NULL

p42/	NULL
p44	NULL
MAPK-phosphorylation	NULL
peaked	NULL
at	NULL
10	NULL
(	NULL
HUVEC	NULL
)	NULL
to	NULL
15	NULL
min	NULL
(	NULL
HAEC	NULL
)	NULL
.	NULL

Discussion	NULL
The	NULL
study	NULL
presented	NULL
demonstrates	NULL
that	NULL
C.	NULL
preumonige	NULL
can	NULL
infect	NULL
and	NULL
activate	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
C.	NULL
preumoniae	NULL
strain	NULL
GiD	NULL
,	NULL
isolated	NULL
from	NULL
a	NULL
man	NULL
with	NULL
bronchitis	NULL
,	NULL
was	NULL
used	NULL
and	NULL
shown	NULL
to	NULL
up-regulate	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
followed	NULL
by	NULL
increased	NULL
rolling	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
transendothelial	NULL
migration	NULL
of	NULL
human	NULL
leukocytes	NULL
(	NULL
PMN	NULL
and	NULL
monocytes	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
reduced	NULL
by	NULL
mAb	NULL
directed	NULL
against	NULL
different	NULL
adhesion	NULL
molecules	NULL
on	NULL
PMN	NULL
(	NULL
B	NULL
;	NULL
inte-grins	NULL
)	NULL
,	NULL
monocytes	NULL
(	NULL
B	NULL
,	NULL
integrins	NULL
,	NULL
VLA	NULL
,	NULL
)	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
ICAM-1	NULL
,	NULL
E-selectin	NULL
,	NULL
VCAM-1	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
observations	NULL
add	NULL
important	NULL
new	NULL
properties	NULL
to	NULL
this	NULL
bacterium	NULL
regarding	NULL
its	NULL
capacity	NULL
to	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
control	NULL
0	NULL
60	NULL
15	NULL
30	NULL
60	NULL
120	NULL
60	NULL
min	NULL
FIGURE	NULL
4	NULL
.	NULL

Role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
C.	NULL
pneumoniae-mediated	NULL
endothelial	NULL
cell	NULL
activation	NULL
.	NULL

This	NULL
aspect	NULL
was	NULL
analyzed	NULL
using	NULL
(	NULL
a	NULL
)	NULL
EMSA	NULL
,	NULL
(	NULL
b	NULL
)	NULL
NF-KB	NULL
reporter	NULL
gene	NULL
assay	NULL
,	NULL
and	NULL
(	NULL
c	NULL
)	NULL
immunofluorescence	NULL
.	NULL

a	NULL
,	NULL
HUVEC	NULL
were	NULL
stimulated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
C.	NULL
preu-	NULL
moniae	NULL
for	NULL
times	NULL
indicated	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
and	NULL
processed	NULL
for	NULL
EMSA	NULL
.	NULL

Note	NULL
enhanced	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
corresponding	NULL
consensus	NULL
oli-	NULL
c	NULL
gonucleotides	NULL
starting	NULL
after	NULL
15	NULL
min	NULL
of	NULL
C.	NULL
preu-	NULL
moniae	NULL
addition	NULL
.	NULL

A	NULL
representative	NULL
gel	NULL
(	NULL
of	NULL
three	NULL
)	NULL
is	NULL
I	NULL
demonstrated	NULL
.	NULL

b	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
confirmed	NULL
by	NULL
enhanced	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
of	NULL
a	NULL
lu	NULL
ciferase	NULL
gene	NULL
transiently	NULL
transfected	NULL
into	NULL
HUVEC	NULL
(	NULL
b	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
details	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
ng/ml	NULL
IL-1B	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
in	NULL
both	NULL
assay	NULL
systems	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

c	NULL
,	NULL
HUVEC	NULL
were	NULL
grown	NULL
on	NULL
glass	NULL
chamber	NULL
slides	NULL
and	NULL
stimulated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
C.	NULL
preumoniae	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
permeabilized	NULL
with	NULL
acetone/methanol	NULL
and	NULL
in	NULL
cubated	NULL
with	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
anti-human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
Ab	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
ALEXA-488-	NULL
conjugated	NULL
goat	NULL
anti-rabbit	NULL
Ig	NULL
Ab	NULL
.	NULL

The	NULL
upper	NULL
picture	NULL
(	NULL
)	NULL
shows	NULL
unstimulated	NULL
control	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
creased	NULL
immunofluorescence	NULL
in	NULL
cell	NULL
nuclei	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
nu	NULL
clear	NULL
NF-KB	NULL
translocation	NULL
)	NULL
is	NULL
demonstrable	NULL
30	NULL
min	NULL
after	NULL
addition	NULL
of	NULL
Chlamydia	NULL
(	NULL
II	NULL
,	NULL
magnification	NULL
X600	NULL
)	NULL
.	NULL

Representative	NULL
pictures	NULL
(	NULL
of	NULL
three	NULL
indepen-	NULL
II	NULL
dent	NULL
experiments	NULL
)	NULL
are	NULL
demonstrated	NULL
.	NULL

initiate	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
leading	NULL
to	NULL
endothelial	NULL
cell	NULL
activation	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
thrombosis	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
endothelial	NULL
cell	NULL
infection	NULL
may	NULL
occur	NULL
directly	NULL
via	NULL
blood-borne	NULL
C.	NULL
pneumoniae	NULL
or	NULL
indirectly	NULL
as	NULL
shown	NULL
by	NULL
recent	NULL
work	NULL
by	NULL
Gaydos	NULL
et	NULL
al	NULL
.	NULL

demonstrating	NULL
that	NULL
C.	NULL
preumoniae	NULL
transfer	NULL
to	NULL
human	NULL
endothelial	NULL
cells	NULL
may	NULL
proceed	NULL
by	NULL
cell-to-cell	NULL
spread	NULL
from	NULL
infected	NULL
adherent	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
mice	NULL
intrana-	NULL
4839	NULL
o	NULL
C.	NULL
pneumoniae	NULL
IL1f	NULL
}	NULL
incubation	NULL
time	NULL
:	NULL
4h	NULL
--	NULL
-	NULL
#	NULL
chemoluminescence	NULL
[	NULL
Ilum/pg	NULL
protein	NULL
]	NULL
x10°	NULL
on	NULL
P	NULL
LO	NULL
none	NULL
4	NULL
3	NULL
2	NULL
1	NULL
LAB	NULL
C.	NULL
pneumoniae	NULL
[	NULL
6.5x10*	NULL
sally	NULL
infected	NULL
with	NULL
C.	NULL
pneumoniae	NULL
showed	NULL
evidence	NULL
of	NULL
systemic	NULL
chlamydial	NULL
dissemination	NULL
via	NULL
macrophages	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Almost	NULL
nothing	NULL
is	NULL
known	NULL
about	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
upon	NULL
target	NULL
cell	NULL
infection	NULL
.	NULL

Our	NULL
studies	NULL
,	NULL
aimed	NULL
to	NULL
identify	NULL
possible	NULL
intracellular	NULL
signaling	NULL
steps	NULL
involved	NULL
,	NULL
indicated	NULL
that	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
MAPK	NULL
activation	NULL
,	NULL
and	NULL
NF-KB	NULL
activation/translocation	NULL
occurred	NULL
within	NULL
10-15	NULL
min	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4840	NULL
a	NULL
kDa	NULL
205	NULL
-	NULL
sap	NULL
97	NULL
-	NULL
%	NULL
ss	NULL
-	NULL
i	NULL
``	NULL
66	NULL
-	NULL
.	NULL

i	NULL
2	NULL
1	NULL
1	NULL
.	NULL

``	NULL
-	NULL
P	NULL
42	NULL
=	NULL
C	NULL
k	NULL
«	NULL
c	NULL
5	NULL
10	NULL
15	NULL
min	NULL
C.	NULL
pneumoniae	NULL
C	NULL
142	NULL
=	NULL
=	NULL
#	NULL
c	NULL
10	NULL
15	NULL
30	NULL
min	NULL
C.	NULL
pneumoniae	NULL
FIGURE	NULL
5	NULL
.	NULL

C.	NULL
preumoniae-induced	NULL
rapid	NULL
total	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
p42/p44	NULL
MAPK	NULL
activation	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
demonstrates	NULL
time	NULL
course	NULL
of	NULL
total	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
a	NULL
)	NULL
,	NULL
and	NULL
p42/p44	NULL
MAPK	NULL
activation	NULL
in	NULL
HUVEC	NULL
(	NULL
5	NULL
)	NULL
and	NULL
HAEC	NULL
(	NULL
c	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
6.5	NULL
X	NULL
10°	NULL
IFU/ml	NULL
for	NULL
0	NULL
(	NULL
control	NULL
)	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
or	NULL
30	NULL
min	NULL
without	NULL
centrifugation	NULL
.	NULL

A	NULL
7.5	NULL
%	NULL
and	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
was	NULL
used	NULL
for	NULL
(	NULL
a	NULL
)	NULL
and	NULL
(	NULL
b	NULL
)	NULL
;	NULL
a	NULL
12.5	NULL
%	NULL
gel	NULL
was	NULL
used	NULL
for	NULL
(	NULL
c	NULL
)	NULL
.	NULL

Representative	NULL
gels	NULL
(	NULL
of	NULL
three	NULL
for	NULL
a	NULL
,	NULL
five	NULL
for	NULL
b	NULL
,	NULL
and	NULL
two	NULL
for	NULL
c	NULL
)	NULL
are	NULL
demonstrated	NULL
.	NULL

Chlamydia	NULL
addition	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

Subsequently	NULL
increased	NULL
mRNA	NULL
levels	NULL
and	NULL
translation	NULL
of	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
were	NULL
noted	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
C.	NULL
pneumoniae	NULL
triggers	NULL
immediate	NULL
events	NULL
of	NULL
cell	NULL
activation	NULL
,	NULL
suggesting	NULL
that	NULL
C.	NULL
pneumoniae	NULL
attachment	NULL
is	NULL
sufficient	NULL
to	NULL
initiate	NULL
an	NULL
endothelial	NULL
response	NULL
and	NULL
that	NULL
bacterial	NULL
uptake	NULL
may	NULL
not	NULL
be	NULL
required	NULL
for	NULL
this	NULL
pro-cess	NULL
.	NULL

Chlamydia	NULL
,	NULL
pretreated	NULL
with	NULL
polymyxin	NULL
B	NULL
to	NULL
inactivate	NULL
LPS	NULL
,	NULL
were	NULL
still	NULL
able	NULL
to	NULL
stimulate	NULL
endothelial	NULL
cells	NULL
,	NULL
while	NULL
heat-killed	NULL
Chlamydia	NULL
did	NULL
not	NULL
induce	NULL
adhesion	NULL
molecule	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
living	NULL
bacteria	NULL
but	NULL
not	NULL
chlamydial	NULL
LPS	NULL
may	NULL
be	NULL
required	NULL
for	NULL
cell	NULL
activation	NULL
.	NULL

After	NULL
initial	NULL
attachment	NULL
,	NULL
Chlamydiae	NULL
are	NULL
internalized	NULL
;	NULL
they	NULL
dissociate	NULL
themselves	NULL
from	NULL
the	NULL
endocytotic	NULL
pathway	NULL
by	NULL
actively	NULL
modifying	NULL
the	NULL
vacuole	NULL
to	NULL
become	NULL
fusogenic	NULL
with	NULL
exocytic	NULL
vesicles	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Interaction	NULL
with	NULL
this	NULL
secretory	NULL
pathway	NULL
appears	NULL
to	NULL
provide	NULL
a	NULL
pathogenic	NULL
mechanism	NULL
that	NULL
allows	NULL
chlamydiae	NULL
to	NULL
establish	NULL
themselves	NULL
in	NULL
a	NULL
site	NULL
that	NULL
is	NULL
not	NULL
destined	NULL
to	NULL
fuse	NULL
with	NULL
lysosomes	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
determine	NULL
the	NULL
relationship	NULL
between	NULL
distinct	NULL
steps	NULL
of	NULL
this	NULL
chlamydial	NULL
development	NULL
cycle	NULL
and	NULL
initiation	NULL
of	NULL
host	NULL
cell	NULL
signaling	NULL
pathways	NULL
.	NULL

Upon	NULL
infection	NULL
with	NULL
intracellular	NULL
pathogens	NULL
,	NULL
NF-KB	NULL
activation	NULL
,	NULL
enhanced	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
increase	NULL
in	NULL
leu-kocytes-target	NULL
cell	NULL
interaction	NULL
may	NULL
be	NULL
an	NULL
uniform	NULL
and	NULL
nonspecific	NULL
endothelial	NULL
cell	NULL
reaction	NULL
.	NULL

Actually	NULL
,	NULL
we	NULL
recently	NULL
reported	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
host	NULL
cell	NULL
activation	NULL
in	NULL
Listeria	NULL
monocytogenes-infected	NULL
endothelial	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
subsequent	NULL
studies	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
identify	NULL
Listeria-induced	NULL
host	NULL
cell-derived	NULL
ceramide	NULL
as	NULL
the	NULL
second	NULL
messenger	NULL
that	NULL
initiated	NULL
NF-KB	NULL
activation	NULL
and	NULL
that	NULL
therefore	NULL
represented	NULL
the	NULL
link	NULL
between	NULL
Listeria	NULL
infection	NULL
and	NULL
endothelial	NULL
cell	NULL
activation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

However	NULL
,	NULL
preliminary	NULL
data	NULL
in	NULL
C.	NULL
pneumoniae-in-fected	NULL
endothelial	NULL
cells	NULL
indicate	NULL
that	NULL
ceramides	NULL
are	NULL
not	NULL
increased	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
in	NULL
case	NULL
of	NULL
Chlamydia	NULL
,	NULL
they	NULL
are	NULL
not	NULL
a	NULL
key	NULL
intracellular	NULL
mediator	NULL
(	NULL
Kriill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
we	NULL
ENDOTHELIAL	NULL
CELL	NULL
INFECTION	NULL
WITH	NULL
Chlamydia	NULL
pneumoniae	NULL
believe	NULL
that	NULL
bacteria-induced	NULL
target	NULL
cell	NULL
activation	NULL
results	NULL
from	NULL
stimulation	NULL
of	NULL
common	NULL
and	NULL
distinct	NULL
(	NULL
dependent	NULL
on	NULL
pathogen-spe-cific	NULL
virulence	NULL
factors	NULL
)	NULL
signaling	NULL
pathways	NULL
in	NULL
host	NULL
cells	NULL
.	NULL

The	NULL
interpretation	NULL
of	NULL
our	NULL
study	NULL
is	NULL
limited	NULL
to	NULL
cultured	NULL
human	NULL
large	NULL
vessel	NULL
endothelial	NULL
cells	NULL
.	NULL

For	NULL
an	NULL
exact	NULL
analysis	NULL
of	NULL
C.	NULL
prew-moniae-related	NULL
alterations	NULL
of	NULL
endothelial	NULL
function	NULL
in	NULL
clinical	NULL
dis-orders	NULL
,	NULL
it	NULL
would	NULL
be	NULL
desirable	NULL
to	NULL
also	NULL
study	NULL
human	NULL
small	NULL
vessel	NULL
endothelial	NULL
cells	NULL
of	NULL
different	NULL
organs	NULL
.	NULL

However	NULL
,	NULL
the	NULL
isolation	NULL
and	NULL
culture	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
sufficient	NULL
quantities	NULL
is	NULL
difficult	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
applicability	NULL
of	NULL
the	NULL
data	NULL
presented	NULL
to	NULL
human	NULL
disease	NULL
must	NULL
be	NULL
verified	NULL
in	NULL
further	NULL
studies	NULL
.	NULL

At	NULL
least	NULL
with	NULL
respect	NULL
to	NULL
large	NULL
vessel	NULL
endothelium	NULL
,	NULL
we	NULL
provided	NULL
data	NULL
demonstrating	NULL
no	NULL
substantial	NULL
difference	NULL
between	NULL
cultured	NULL
human	NULL
large	NULL
vein	NULL
and	NULL
aortic	NULL
endothelial	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
C.	NULL
pneumoniae	NULL
can	NULL
infect	NULL
HUVEC	NULL
and	NULL
HAEC	NULL
and	NULL
activate	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
:	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
MAPK	NULL
stimulation	NULL
,	NULL
and	NULL
activation/translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
occurred	NULL
within	NULL
minutes	NULL
.	NULL

Within	NULL
hours	NULL
,	NULL
increased	NULL
mRNA	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
VCAM-1	NULL
was	NULL
noted	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
resulted	NULL
in	NULL
enhanced	NULL
leukocyte	NULL
(	NULL
monocytes	NULL
,	NULL
PMN	NULL
)	NULL
-HUVEC	NULL
interaction	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
suggest	NULL
that	NULL
C.	NULL
preumoniae	NULL
infection	NULL
triggers	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
that	NULL
could	NULL
lead	NULL
to	NULL
endothelial	NULL
damage	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
thrombosis	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
H.	NULL
Geisel	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

Parts	NULL
of	NULL
this	NULL
work	NULL
will	NULL
be	NULL
included	NULL
in	NULL
the	NULL
MD	NULL
thesis	NULL
of	NULL
A.	NULL
C.	NULL
Klucken	NULL
and	NULL
C.	NULL
Magerl	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
the	NULL
staff	NULL
of	NULL
the	NULL
Delivery-Services	NULL
of	NULL
the	NULL
Krankenhaus	NULL
Ehringshausen	NULL
,	NULL
Dil-lenburg	NULL
,	NULL
and	NULL
Lich	NULL
for	NULL
invaluable	NULL
help	NULL
in	NULL
collecting	NULL
umbilical	NULL
cords	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Grayston	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
C.-C.	NULL
Kuo	NULL
,	NULL
S.-P.	NULL
Wang	NULL
,	NULL
and	NULL
J.	NULL
Altman	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
new	NULL
Chlamydia	NULL
psittaci	NULL
strain	NULL
called	NULL
TWAR	NULL
from	NULL
acute	NULL
respiratory	NULL
tract	NULL
infections	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

315:161	NULL
.	NULL

2	NULL
.	NULL

Grayston	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
L.	NULL
A.	NULL
Campbell	NULL
,	NULL
C.-C.	NULL
Kuo	NULL
,	NULL
C.	NULL
Mordhorst	NULL
,	NULL
P.	NULL
Saikku	NULL
,	NULL
D.	NULL
Thom	NULL
,	NULL
and	NULL
S.-P.	NULL
Wang	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
new	NULL
respiratory	NULL
tract	NULL
pathogen	NULL
:	NULL
Chlamydia	NULL
pneumoniae	NULL
,	NULL
strain	NULL
TWAR	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

161:618	NULL
.	NULL

3	NULL
.	NULL

Grayston	NULL
,	NULL
J.	NULL
T.	NULL
1992	NULL
.	NULL

Infections	NULL
caused	NULL
by	NULL
Chlamydia	NULL
pneumoniae	NULL
strain	NULL
TWAR	NULL
.	NULL

Clin	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

15:757	NULL
.	NULL

4	NULL
.	NULL

Shor	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Kuo	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Patton	NULL
.	NULL

1992	NULL
.	NULL

Detection	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
in	NULL
coronary	NULL
arterial	NULL
fatty	NULL
streaks	NULL
and	NULL
atheromatous	NULL
plaques	NULL
.	NULL

S.	NULL
Afr	NULL
.	NULL

Med	NULL
.	NULL

J	NULL
.	NULL

82	NULL
:	NULL
158	NULL
.	NULL

5	NULL
.	NULL

Thom	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
J.	NULL
T.	NULL
Grayston	NULL
,	NULL
D.	NULL
S.	NULL
Siscovick	NULL
,	NULL
S.-P.	NULL
Wang	NULL
,	NULL
N.	NULL
S.	NULL
Weiss	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Daling	NULL
.	NULL

1992	NULL
.	NULL

Association	NULL
of	NULL
prior	NULL
infection	NULL
with	NULL
Chlamydia	NULL
pneumoniae	NULL
and	NULL
angiographically	NULL
demonstrated	NULL
coronary	NULL
artery	NULL
disease	NULL
.	NULL

JAMA	NULL
267:68	NULL
.	NULL

6	NULL
.	NULL

Kuo	NULL
,	NULL
C.-C.	NULL
,	NULL
A.	NULL
Shor	NULL
,	NULL
L.	NULL
A.	NULL
Campbell	NULL
,	NULL
H.	NULL
Fukushi	NULL
,	NULL
D.	NULL
L.	NULL
Patton	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Grayston	NULL
.	NULL

1993	NULL
.	NULL

Demonstration	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
in	NULL
atherosclerotic	NULL
lesions	NULL
of	NULL
coronary	NULL
arteries	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

167:841	NULL
.	NULL

7	NULL
.	NULL

Saikku	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
Mattila	NULL
,	NULL
M.	NULL
S.	NULL
Nieminen	NULL
,	NULL
J.	NULL
K.	NULL
Huttunen	NULL
,	NULL
M.	NULL
Leinonen	NULL
,	NULL
M.-R.	NULL
Ekman	NULL
,	NULL
P.	NULL
H.	NULL
Miikel	NULL
#	NULL
,	NULL
and	NULL
V.	NULL
Valtonen	NULL
.	NULL

1988	NULL
.	NULL

Serological	NULL
evidence	NULL
of	NULL
an	NULL
association	NULL
of	NULL
a	NULL
novel	NULL
Chlamydia	NULL
,	NULL
TWAR	NULL
,	NULL
in	NULL
adults	NULL
with	NULL
chronic	NULL
coronary	NULL
heart	NULL
disease	NULL
and	NULL
acute	NULL
myocardial	NULL
infarction	NULL
.	NULL

Lancet	NULL
2:983	NULL
.	NULL

8	NULL
.	NULL

Saikku	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Leinonen	NULL
,	NULL
L.	NULL
Tenkanen	NULL
,	NULL
E.	NULL
Linnanmaki	NULL
,	NULL
M.-R.	NULL
Ekman	NULL
,	NULL
M.	NULL
Manttari	NULL
,	NULL
M.	NULL
H.	NULL
Frick	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Huttunen	NULL
.	NULL

1992	NULL
.	NULL

Chronic	NULL
Chlamydia	NULL
preumoniae	NULL
infection	NULL
as	NULL
a	NULL
risk	NULL
factor	NULL
for	NULL
coronary	NULL
heart	NULL
disease	NULL
in	NULL
the	NULL
Helsinki	NULL
heart	NULL
study	NULL
.	NULL

Ann	NULL
.	NULL

Inf	NULL
.	NULL

Med	NULL
.	NULL

116:273	NULL
.	NULL

9	NULL
.	NULL

Kaukoranta-Tolvanen	NULL
,	NULL
S.-S.	NULL
E.	NULL
,	NULL
K.	NULL
Laitinen	NULL
,	NULL
P.	NULL
Saikku	NULL
,	NULL
and	NULL
M.	NULL
Leinonen	NULL
.	NULL

1994	NULL
.	NULL

Chlamydia	NULL
pneumoniae	NULL
multiplies	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Microb	NULL
.	NULL

Pathog	NULL
.	NULL

16:313	NULL
.	NULL

10	NULL
.	NULL

Godzik	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
E.	NULL
R.	NULL
O'Brien	NULL
,	NULL
S.-K.	NULL
Wang	NULL
,	NULL
and	NULL
C.-C.	NULL
Kuo	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vitro	NULL
susceptibility	NULL
of	NULL
human	NULL
vascular	NULL
wall	NULL
cells	NULL
to	NULL
infection	NULL
with	NULL
Chlamydia	NULL
pneumoniae	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

33:2411	NULL
.	NULL

11	NULL
.	NULL

Gaydos	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Summersgill	NULL
,	NULL
N.	NULL
N.	NULL
Sabhney	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ramirez	NULL
,	NULL
and	NULL
T.	NULL
C.	NULL
Quinn	NULL
.	NULL

1996	NULL
.	NULL

Replication	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
in	NULL
vitro	NULL
in	NULL
human	NULL
macrophages	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
aortic	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

64:1614	NULL
.	NULL

12	NULL
.	NULL

Kaukoranta-Tolvanen	NULL
,	NULL
S.-S.	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Teppo	NULL
,	NULL
K.	NULL
Laitinen	NULL
,	NULL
P.	NULL
Saikku	NULL
,	NULL
K.	NULL
Linnavuori	NULL
,	NULL
and	NULL
M.	NULL
Leinonen	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
in	NULL
cultured	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
induction	NULL
of	NULL
a	NULL
cytokine	NULL
response	NULL
.	NULL

Microb	NULL
.	NULL

Pathog	NULL
.	NULL

21:215	NULL
.	NULL

13	NULL
.	NULL

Heinemann	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Susa	NULL
,	NULL
U.	NULL
Simnacher	NULL
,	NULL
R.	NULL
Marre	NULL
,	NULL
and	NULL
A.	NULL
Essig	NULL
.	NULL

1996	NULL
.	NULL

Growth	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
induces	NULL
cytokine	NULL
production	NULL
and	NULL
expression	NULL
of	NULL
CD14	NULL
in	NULL
a	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

64:4872	NULL
.	NULL

14	NULL
.	NULL

Carlos	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Harlan	NULL
.	NULL

1994	NULL
.	NULL

Leukocyte-endothelial	NULL
adhesion	NULL
molecules	NULL
.	NULL

Blood	NULL
84:2068	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Albelda	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
C.	NULL
W.	NULL
Smith	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Ward	NULL
.	NULL

1994	NULL
.	NULL

Adhesion	NULL
molecules	NULL
and	NULL
inflammatory	NULL
injury	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

8:504	NULL
.	NULL

Butcher	NULL
,	NULL
E.	NULL
C.	NULL
1991	NULL
.	NULL

Leukocyte-endothelial	NULL
cell	NULL
recognition	NULL
:	NULL
three	NULL
(	NULL
or	NULL
more	NULL
)	NULL
steps	NULL
to	NULL
specificity	NULL
and	NULL
diversity	NULL
.	NULL

Cell	NULL
67:1033	NULL
.	NULL

Moore	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
K.	NULL
D.	NULL
Patel	NULL
,	NULL
R.	NULL
E.	NULL
Bruchl	NULL
,	NULL
L.	NULL
Fugang	NULL
,	NULL
D.	NULL
A.	NULL
Johnson	NULL
,	NULL
H.	NULL
S.	NULL
Lichenstein	NULL
,	NULL
R.	NULL
D.	NULL
Cummings	NULL
,	NULL
D.	NULL
F.	NULL
Bainton	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
McEver	NULL
.	NULL

1995	NULL
.	NULL

P-selectin	NULL
glycoprotein	NULL
ligand-1	NULL
mediates	NULL
rolling	NULL
of	NULL
human	NULL
neutrophils	NULL
on	NULL
P-selectin	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

128:661	NULL
.	NULL

Tedder	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
D.	NULL
A.	NULL
Steeber	NULL
,	NULL
A.	NULL
Chen	NULL
,	NULL
and	NULL
P.	NULL
Engel	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
selectins	NULL
:	NULL
vascular	NULL
adhesion	NULL
molecules	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

9:866	NULL
.	NULL

Levinovitz	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
MihThoff	NULL
,	NULL
S.	NULL
Isenmann	NULL
,	NULL
and	NULL
D.	NULL
Vestweber	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
glycoprotein	NULL
ligand	NULL
for	NULL
E-selectin	NULL
on	NULL
mouse	NULL
myeloid	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

121:449	NULL
.	NULL

Roblin	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
W.	NULL
Dumornay	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Hammerschlag	NULL
.	NULL

1992	NULL
.	NULL

Use	NULL
of	NULL
HEp-2	NULL
cells	NULL
for	NULL
improved	NULL
isolation	NULL
and	NULL
passage	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

30:1968	NULL
.	NULL

Wong	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
S.	NULL
K.	NULL
Skelton	NULL
,	NULL
and	NULL
Y.	NULL
K.	NULL
Chan	NULL
.	NULL

1992	NULL
.	NULL

Efficient	NULL
culture	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
with	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
respiratory	NULL
tract	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

30:1625	NULL
.	NULL

Ward	NULL
,	NULL
M.	NULL
E.	NULL
1988	NULL
.	NULL

The	NULL
chlamydial	NULL
development	NULL
cycle	NULL
.	NULL

In	NULL
Microbiology	NULL
of	NULL
Chla-mydia	NULL
.	NULL

A.	NULL
L.	NULL
Barron	NULL
,	NULL
ed	NULL
.	NULL

CRC	NULL
press	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
.	NULL

,	NULL
p.	NULL
71-97	NULL
.	NULL

Beatty	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
P.	NULL
Morrison	NULL
,	NULL
and	NULL
G.	NULL
I.	NULL
Byrne	NULL
.	NULL

1994	NULL
.	NULL

Persistent	NULL
Chlamydiae	NULL
:	NULL
from	NULL
cell	NULL
culture	NULL
to	NULL
a	NULL
paradigm	NULL
for	NULL
chlamydial	NULL
pathogenesis	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

58:686	NULL
.	NULL

Moulder	NULL
,	NULL
J.	NULL
W.	NULL
1991	NULL
.	NULL

Interaction	NULL
of	NULL
Chlamydiae	NULL
and	NULL
host	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

55:143	NULL
.	NULL

Jaffe	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
R.	NULL
L.	NULL
Nachman	NULL
,	NULL
C.	NULL
G.	NULL
Becker	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mimnick	NULL
.	NULL

1973	NULL
.	NULL

Culture	NULL
of	NULL
human	NULL
endothelial	NULL
cells	NULL
derived	NULL
from	NULL
umbilical	NULL
veins	NULL
:	NULL
identification	NULL
by	NULL
morpho-logic	NULL
and	NULL
immunologic	NULL
criteria	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

52:2745	NULL
.	NULL

Suttorp	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Polley	NULL
,	NULL
J.	NULL
Seybold	NULL
,	NULL
H.	NULL
Schnittler	NULL
,	NULL
W.	NULL
Seeger	NULL
,	NULL
F.	NULL
Grimminger	NULL
,	NULL
and	NULL
K.	NULL
Aktories	NULL
.	NULL

1991	NULL
.	NULL

Adenosine	NULL
diphosphate-ribolysation	NULL
of	NULL
G-actin	NULL
by	NULL
botulinum	NULL
C2	NULL
toxin	NULL
increases	NULL
endothelial	NULL
permeability	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:1575	NULL
.	NULL

Suttorp	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Weber	NULL
,	NULL
T.	NULL
Welsch	NULL
,	NULL
and	NULL
C.	NULL
Schudt	NULL
.	NULL

1993	NULL
Role	NULL
of	NULL
phosphodiester	NULL
ases	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
endothelial	NULL
permeability	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91	NULL
:	NULL
1421	NULL
.	NULL

Kriill	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Dold	NULL
,	NULL
S.	NULL
Hippenstiel	NULL
,	NULL
S.	NULL
Rosseau	NULL
,	NULL
J.	NULL
Lohmeyer	NULL
,	NULL
and	NULL
N.	NULL
Suttorp	NULL
.	NULL

1996	NULL
.	NULL

Escherichia	NULL
coli	NULL
hemolysin	NULL
and	NULL
Staphylococcus	NULL
aureus	NULL
a-toxin	NULL
potently	NULL
induce	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
cultured	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
;	NULL
4133	NULL
.	NULL

Suttorp	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Fuhrmann	NULL
,	NULL
S.	NULL
Tannert-Ofto	NULL
,	NULL
and	NULL
S.	NULL
Bhakdi	NULL
.	NULL

1993	NULL
.	NULL

Pore-forming	NULL
bacterial	NULL
toxins	NULL
potently	NULL
induce	NULL
release	NULL
of	NULL
nitric	NULL
oxide	NULL
in	NULL
porcine	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:337	NULL
.	NULL

Figdor	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
W.	NULL
S.	NULL
Bont	NULL
,	NULL
J.	NULL
E.	NULL
De	NULL
Vries	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
Van	NULL
Es	NULL
.	NULL

1981	NULL
.	NULL

Isolation	NULL
of	NULL
large	NULL
numbers	NULL
of	NULL
highly	NULL
purified	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
with	NULL
a	NULL
modified	NULL
centrifugal	NULL
elutriation	NULL
technique	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
40:275	NULL
.	NULL

Jantos	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
S.	NULL
Heck	NULL
,	NULL
R.	NULL
Roggendorf	NULL
,	NULL
M.	NULL
Sen-Gupta	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Hegemann	NULL
.	NULL

1997	NULL
.	NULL

Antigenic	NULL
and	NULL
molecular	NULL
analysis	NULL
of	NULL
different	NULL
Chlamydia	NULL
pneumoniae	NULL
strains	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

35:620	NULL
.	NULL

Kriill	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Nost	NULL
,	NULL
S.	NULL
Hippenstiel	NULL
,	NULL
E.	NULL
Domann	NULL
,	NULL
T.	NULL
Chakraborty	NULL
,	NULL
and	NULL
N.	NULL
Suttorp	NULL
.	NULL

Listeria	NULL
monocytogenes	NULL
potently	NULL
induces	NULL
up-regulation	NULL
of	NULL
endothelial	NULL
adhesion	NULL
molecules	NULL
and	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
cultured	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1970	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

4841	NULL
Lawrence	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1991	NULL
.	NULL

Leukocytes	NULL
roll	NULL
on	NULL
a	NULL
selectin	NULL
at	NULL
physiologic	NULL
flow	NULL
rates	NULL
:	NULL
distinction	NULL
from	NULL
and	NULL
prerequisite	NULL
for	NULL
adhesion	NULL
through	NULL
integrins	NULL
.	NULL

Cell	NULL
65:859	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
227:680	NULL
.	NULL

Newton	NULL
,	NULL
R.	NULL
,	NULL
I.	NULL
M.	NULL
Adcock	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Barnes	NULL
.	NULL

1996	NULL
.	NULL

Superinduction	NULL
of	NULL
NF-KB	NULL
by	NULL
actinomycin	NULL
D	NULL
and	NULL
cycloheximide	NULL
in	NULL
epithelial	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

218:518	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single	NULL
step	NULL
method	NULL
for	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
;	NULL
156	NULL
.	NULL

Giembycz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
C.	NULL
J.	NULL
Corrigan	NULL
,	NULL
J.	NULL
Seybold	NULL
,	NULL
R.	NULL
Newton	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Barnes	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
cyclic	NULL
AMP	NULL
phosphodiesterases	NULL
3	NULL
,	NULL
4	NULL
and	NULL
7	NULL
in	NULL
human	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T-lymphocytes	NULL
:	NULL
role	NULL
in	NULL
regulating	NULL
proliferation	NULL
and	NULL
the	NULL
synthesis	NULL
of	NULL
inter-leukin-2	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

118:1945	NULL
.	NULL

Dunn	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
V.	NULL
A.	NULL
Clark	NULL
.	NULL

1974	NULL
.	NULL

Applied	NULL
Statistics	NULL
:	NULL
Analysis	NULL
of	NULL
Variance	NULL
and	NULL
Regression	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Fryer	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
E.	NULL
P.	NULL
Schwobe	NULL
,	NULL
M.	NULL
L.	NULL
Woods	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rodgers	NULL
.	NULL

1997	NULL
.	NULL

Chlamydia	NULL
species	NULL
infect	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
and	NULL
induce	NULL
procoagulant	NULL
activity	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Med	NULL
.	NULL

45:168	NULL
.	NULL

Manning	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
C.	NULL
C.	NULL
Chen	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
:	NULL
a	NULL
dominant	NULL
role	NULL
for	NULL
NF-B	NULL
.	NULL

Agents	NULL
Actions	NULL
Suppl	NULL
.	NULL

47	NULL
:	NULL
135	NULL
.	NULL

Collins	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Williams	NULL
,	NULL
G.	NULL
L	NULL
Johnston	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
T.	NULL
Shows	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Bevilacqua	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
and	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
.	NULL

J.	NULL
Biol	NULL
Chem	NULL
.	NULL

266:2466	NULL
.	NULL

Vorarberger	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Schiifer	NULL
,	NULL
and	NULL
C.	NULL
Stratowa	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
and	NULL
analysis	NULL
of	NULL
its	NULL
5'-regulatory	NULL
region	NULL
:	NULL
induction	NULL
by	NULL
cytokines	NULL
and	NULL
phorbol	NULL
ester	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2777	NULL
.	NULL

Cybulsky	NULL
,	NULL
M.	NULL
L	NULL
,	NULL
J.	NULL
W.	NULL
Fries	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
P.	NULL
Sultan	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
M.	NULL
Byers	NULL
,	NULL
T.	NULL
Shows	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1991	NULL
.	NULL

Gene	NULL
structure	NULL
,	NULL
chromosomal	NULL
location	NULL
,	NULL
and	NULL
basis	NULL
for	NULL
alternative	NULL
mRNA	NULL
splicing	NULL
of	NULL
the	NULL
human	NULL
VCAM1	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7859	NULL
.	NULL

Gaydos	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
D.	NULL
G.	NULL
Pham	NULL
,	NULL
and	NULL
T.	NULL
C.	NULL
Quinn	NULL
.	NULL

1996	NULL
.	NULL

Chlamydia	NULL
pneumoniae	NULL
infections	NULL
in	NULL
macrophages	NULL
and	NULL
coronary	NULL
artery	NULL
endothelial	NULL
cells	NULL
.	NULL

In	NULL
Proceedings	NULL
Third	NULL
Meeting	NULL
of	NULL
the	NULL
European	NULL
Society	NULL
for	NULL
Chlamydia	NULL
Research	NULL
,	NULL
Vol.3	NULL
.	NULL

A.	NULL
Stary	NULL
,	NULL
ed	NULL
.	NULL

Societa	NULL
Editrice	NULL
Esculapio	NULL
,	NULL
Bologna	NULL
,	NULL
p.	NULL
89	NULL
.	NULL

Moazed	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
C.-C.	NULL
Kuo	NULL
,	NULL
J.	NULL
T.	NULL
Grayston	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Campbell	NULL
.	NULL

1998	NULL
.	NULL

Evidence	NULL
of	NULL
systemic	NULL
dissemination	NULL
of	NULL
Chlamydia	NULL
pneumoniae	NULL
via	NULL
macrophages	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

177:1322	NULL
.	NULL

Hacksted	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
R.	NULL
Fischer	NULL
,	NULL
M.	NULL
A.	NULL
Scidmore	NULL
,	NULL
D.	NULL
D.	NULL
Rockey	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Heinzen	NULL
.	NULL

1997	NULL
.	NULL

Origins	NULL
and	NULL
functions	NULL
of	NULL
the	NULL
chlamydial	NULL
inclusion	NULL
.	NULL

Trends	NULL
Microbiol	NULL
5:288	NULL
.	NULL

Schwarzer	NULL
,	NULL
N.	NULL
,	NULL
R.	NULL
Nost	NULL
,	NULL
J.	NULL
Seybold	NULL
,	NULL
S.	NULL
K.	NULL
Parida	NULL
,	NULL
O.	NULL
Fuhrmann	NULL
,	NULL
M.	NULL
Kriill	NULL
,	NULL
R.	NULL
Schmidt	NULL
,	NULL
R.	NULL
Newton	NULL
,	NULL
S.	NULL
Hippensticl	NULL
,	NULL
E.	NULL
Domann	NULL
,	NULL
T.	NULL
Chakraborty	NULL
,	NULL
and	NULL
N.	NULL
Suttorp	NULL
.	NULL

1998	NULL
.	NULL

Two	NULL
distinct	NULL
phospholipases	NULL
C	NULL
of	NULL
Listeria	NULL
monocytogenes	NULL
induce	NULL
ceramide	NULL
generation	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
activation	NULL
,	NULL
and	NULL
E-selectin	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3010	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

